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Background: Female Genital Mutilation/C (FGM/C) is cultural practice associated with adverse 
obstetric, reproductive, and gynecologic health outcomes and no health benefits. Although more 
than 200 million women and girls have already been affected around the world, there are no 
validated instruments to assess health care providers for the care of women affected by FGM/C.  
Methods: Using an explanatory sequential quantitative-qualitative design, we psychometrically 
assessed novel measures of health care provider attitudes and confidence for FGM/C care using 
exploratory factor analysis (EFA), explored the relationship between provider characteristics and 
health care provider attitudes and confidence using multivariable linear regression, and 
conducted in-depth qualitative interviews to explore expert opinion on the areas of knowledge, 
attitudes and practices that contribute to quality care for FGM/C.  
Results: The EFA for attitudes resulted in subscales for Negative Attitudes and Empathetic 
Attitudes with Cronbach’s alphas of 0.814 and 0.628 respectively. The EFA for confidence 
resulted in subscales for Confidence in Clinical FGM/C Care and Confidence in Critical 
Communication Skills for FGM/C with Cronbach’s alphas of 0.857 and 0.694 respectively. The 
only statistically significant factor associated with either negative or empathetic attitudes was 
that women had significantly less Negative Attitudes compared to men. Factors associated with 
higher Confidence for Clinical FGM/C Care scores include awareness of health complications, 
having cared for a woman with FGM/C, being a woman or a person of color, and more than 5 
years clinical practice. The only factor associated with increased Confidence in Critical 
Communication Skills for FGM/C Care was awareness of health complications of FGM/C. 
Participants in our qualitative study identified six areas of knowledge, six of practice, and seven 
of attitudes that contribute to quality care for FGM/C. We present prominent themes that 
 iii 
describe how the interaction between knowledge, attitudes and practices influence quality of 
care. 
Conclusion: The study described herein combines rigorous psychometric analysis of measures 
of health care providers attitudes and confidence for FGM/C care in the US, and a qualitative 
exploration of expert opinion to advance our understanding of the knowledge, attitudes, and 
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This dissertation is organized into five chapters. The first chapter provides background on 
the problem addressed by this research, an explanation of key concepts, a review of existing 
literature, and provides the conceptual frameworks used to guide analyses.  
Chapter Two (Manuscript One) presents the findings of the psychometric validation of 
the Attitudes and Confidence Scales developed to assess health care providers caring for women 
and girls affected by FGM/C. These scales were validated using exploratory factor analysis. This 
chapter also presents hypothesis testing to assess the concurrent validity of the newly validated 
scales.  
Chapter Three (Manuscript Two) presents the findings of the multivariate analysis that 
aimed to explore factors associated with health care provider awareness of complications, 
attitudes toward FGM/C, and confidence for the care for women affected by FGM/C. 
Chapter Four (Manuscript Three) presents the findings of the qualitative study that aims 
to explore and expand upon the domains of knowledge, attitudes and practices for the care of 
women and girls affected by FGMC. This chapter provides details regarding the qualitative data 
collection, analysis, and creation of a domain framework.  
Chapter Five provides a summary of results and discusses integration of results across the 
three manuscripts and within other existing literature. The chapter discusses implications of these 
results for future research, interventions, and policies. 
  
 2 
CHAPTER 1: INTRODUCTION 
Background and Rationale 
200 million women and girls around the world that are affected by female genital 
mutilation/ cutting (FGM/C) require specialized health care to reduce disability and maximize 
quality of life.1,2 FGM/C includes procedures that intentionally alter or cause hard to female 
genital organs for non-medical reasons, and may result in a number of adverse obstetric, 
gynecologic, urologic, and psychosexual consequences.1,3 Despite the prevalence of FGM/C and 
its associated morbidities, there is not a validated instrument to assess health care provider 
knowledge for the care of affected populations.4–6 Many health care providers (nurses, nurse 
practitioners, social workers, and physicians) have limited or no training in the identification and 
care of women/ girls with FGMC. 4,6–10 The lack of technical knowledge about the physical and 
psychosexual consequences of FGM/C, limited cultural competence and socio-cultural 
challenges, and lack of guidance of best practices for the care of women with FGMC result in 
health disparities compared to non-FGMC affected women, and adverse reproductive health 
outcomes.11  
 Despite a fall in overall prevalence rates, the number of girls and women affected will 
rise, in coming decades because of persistently high fertility rates in FGM/C practicing 
countries.1 Because of global migration trends, health care providers in countries where FGM/C 
is not normative are likely to care for affected women and girls.1 FGMC may result in a number 
of adverse outcomes including but not limited to: obstetric (hemorrhage, cesarean section), 
gynecologic (recurrent infections), urologic (painful urination), and psychosexual (painful 
intercourse, anxiety, depression).12–18  
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 Health care provider capacity around FGMC is often measured using a “Knowledge, 
Attitudes, and Practices” (KAP) framework; however, there is no standard or validated 
instrument to assess health care provider KAP. Existing studies design their own KAP 
instrument, often with very different items, limiting the comparability and generalizability of the 
findings. This lack of a reliable, valid tool limits efforts to adequately assess provider readiness 
to care for this population or gauge the success of efforts designed to improve their 
competencies.  Centers for Disease Control (CDC) and WHO have on-going studies that include 
trainings for health care providers on caring for FGMC affected populations, but lack a validated 
instrument to assess trainings.  
 This overall goal of the study is to improve the assessment of health care providers caring 
for women and girls affected by FGM/C. We achieved this goal by addressing three specific 
aims. First, we constructed and assessed the reliability and validity of novel Attitudes and 
Confidence Scales to assess health care providers caring for women and girls affected by FGM/C 
in the US. These scales were validated using exploratory factor analysis. We further performed 
hypothesis testing to assess the concurrent validity of the newly validated scales. Second, using 
multivariate analysis, we explored factors associated with health care provider awareness of 
complications, attitudes toward FGM/C, and confidence for the care for women affected by 
FGM/C in the US context. Third, we conducted a qualitative study utilizing in depth interviews 
with clinical and research experts on FGM/C to explore and expand upon the domains of 
knowledge, attitudes and practices for the care of women and girls affected by FGM/C in a 
global context.  
Improved assessment methods are critically needed so that health care organizations can 
evaluate health care providers caring for women and girls affected by FGM/C. This may include 
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The overall purpose of this dissertation was to construct and psychometrically assess 
measures of health care provider attitudes and confidence for the care of women and girls 
affected by FGM/C, and to advance our understanding of the knowledge, attitudes, and practices 
of health care providers that contribute to quality care for women and girls affected by FGM/C. 
This explanatory sequential quantitative-qualitative study will 1) construct and validate novel 
measures of health care provider attitudes and confidence for FGM/C care, 2) examine the 
relationship between health care provider attitudes and confidence for FGM/C care and other 
health care provider experiences and characteristics, and 3) explore knowledge, attitudes and 
practices important for quality care through qualitative interviews with clinical and research 
experts for FGM/C care. The quantitative study occurred first in order to rapidly develop and 
validate a measure for use in an ongoing research study at Arizona State University that aimed to 
conduct baseline assessments and training of US health care providers for FGM/C care. The 
qualitative study was conducted in collaboration with the World Health Organization Office of 
Reproductive Health and Research and aimed to create a framework for the development of a 
comprehensive knowledge, attitudes, and practices measure for use global settings.  
This study can improve the quality of assessment through the development of 
standardized measures to assess health care provider attitudes and confidence for the care of this 
vulnerable population (minority women and affected by FGM/C) in the US context. This data 
can inform future trainings that aim to transform attitudes and increase US health care provider 
confidence for the provision of care to this marginalized population. By exploring the expert 
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opinion of a global sample of clinical and research experts in FGM/C, we can further advance 
our understanding of what comprises quality care, and design comprehensive training 




The following specific aims were proposed:  
Specific Aim 1 (Quantitative) Assess the psychometric properties and factor structure of novel 
measures of health care provider attitudes and confidence for the care of women and girls 
affected by FGM/C. 
Specific Aim 1.1 Utilize exploratory factor analysis to assess the factor structure and 
psychometric properties of the newly developed attitudes scale. 
Specific Aim 1.2 Assess concurrent validity of the attitudes scale by testing the following 
hypotheses: 
Hypothesis 1.2.1: Health care providers who have cared for women or girls 
affected by FGMC, received training on FGM/C, who identify as nurses/ mental 
health/ social workers, providers specializing in women’s health, women, and 
people of color will have more empathetic and less negative attitudes than health 
care providers who have not had these experiences or who do not share these 
characteristics. 
Specific Aim 1.3 Utilize exploratory factor analysis to test the factor structure and 
psychometric properties of the newly developed confidence scale. 
Specific Aim 1.4 Assess the concurrent validity by testing the following hypotheses: 
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Hypothesis 1.4.1: Health care providers who have cared for women or girls 
affected by FGM/C, received training on FGM/C, and who specialize in women’s 
health will have higher scores on the confidence subscales compared to health 
care providers who have never cared for a woman or girl affected by FGMC. 
Specific Aim #2 (Quantitative) Explore the relationship between health care provider 
demographic characteristics, previous clinical experience related to FGM/C, awareness of health 
complications associated with FGM/C, attitudes towards FGM/C and those who practice 
FGM/C, and confidence for the care of women and girls affected by FGM/C using multivariable 
regression. 
Exploratory Aim 2.1 Explore the relationship between health care provider awareness of 
complications of FGM/C and demographic factors, previous clinical experience related to 
FGM/C. 
Exploratory Aim 2.2 Explore the relationship between health care provider Negative 
Attitudes Toward FGM/C and those who practice and demographic factors, previous 
clinical experience related to FGM/C, and awareness of health complications of FGM/C.  
Exploratory Aim 2.3 Explore the relationship between health care provider Empathetic 
Attitudes Toward FGM/C and those who practice and demographic factors, previous 
clinical experience related to FGM/C, and awareness of health complications of FGM/C.  
Exploratory Aim 2.1.4 Explore the relationship between health care provider Confidence 
for Clinical FGM/C Care and demographic factors, previous clinical experience related 
to FGM/C, and awareness of health complications of FGM/C.  
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Exploratory Aim 2.5 Explore the relationship between health care provider Confidence in 
Critical Communication Skills for FGM/C and demographic factors, previous clinical 
experience related to FGM/C, and awareness of health complications of FGM/C.  
Specific Aim #3 (Qualitative) Explore the knowledge, attitudes, and practices that global 
clinical and research experts in FGM/C consider important to ensure high quality, safe, and 





This study was guided by the Knowledge, Attitudes, and Practices (KAP) framework which is 
often used to assess health behaviors, including the behaviors of health care providers during the 
course of care provision. The KAP framework seeks to address the relationship between 
knowledge and behavior, theorizing that attitudes may affect the relationship. The KAP framework 
theorizes that an individual learns about a topic (knowledge), develops some affective response 
(attitude), and engages in a behavior (practice) – often these factors influence one another in 
multidirectional ways.19 See Figure #1.  






In order to create an effective measure of health care provider knowledge, attitudes and practices 
for FGM/C, it is imperative that researchers define what constitutes critical knowledge for 
FGM/C, attitudes that affect FGM/C care, and practices that constitute quality care for FGM/C. 
However, at the outset of this dissertation research in 2017, there was no current published 
comprehensive guide that enumerated what constituted quality care for women and girls living 
with FGM/C. During the course of this research, the WHO published a Care of Women and Girls 
Living with Female Genital Mutilation: A Clinical Handbook which provides a comprehensive 
overview of the knowledge and practices that constitute quality care. The Clinical Handbook 
does not provide a comprehensive framework of how attitudes contribute to the patient’s 
experience of quality care  
 As we sought the develop a measure of health care provide attitudes toward FGM/C, and 
an interview guide to explore the concept of attitudes in the context of FGM/C care, we utilized 
the conceptualization of attitudes theory to inform our work.20,21 This theory proposes that 
attitudes are constructed through the reciprocal interplay of affect, belief, and behavior and can 
be the tendency that is expressed as we assign particular entity or concept with favor or 
disfavor.22 Affect is the feeling that an individual may experience in relation to the concept under 
investigation. The way a provider feels about FGM will affect how they feel about the 
performance of FGM, the women who undergo/ have undergone FGM, and the communities that 
practice FGM. Beliefs are thoughts about the relationship between a concept and a given 
attribute; for example, an individual may believe that FGM/C is a barbaric practice, or alternately 
that it is a culturally beneficial practice. Individuals process their experiences, observations, 
knowledge, and culture regarding a concept and develop a belief about the value, causes, and 
outcomes of the object/ experience. The beliefs of health care providers related to FGM will be 
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explored in qualitative interviews in order to better understand the range of beliefs providers may 
hold, and how those beliefs affect the care that they provide. Behaviors include the actions taken 
by the individual and may be influenced by selective attention to certain affective responses or 
beliefs, while disregarding others. In the case of FGM, health care provider behavior may be 
related to unconscious or learned patterns of behavior based on past experience or may depend 
on how much exposure a health care provider has had to FGM and under what circumstances. 
The relationship between behaviors and beliefs/ affect may be inconsistent and depend factors 
related to the individual health care provider, their clinical training, and their clinical practice.  
 In order to create the items to measure health care provider attitudes, we next had to 
determine attitudes toward which object were important to the provision of quality care for 
FGM/C. Based on our exploration of qualitative literature of the experiences of women with 
FGM/C receiving care, and health care providers experiences providing care to those affected by 
FGM/C, we determined that there were three types of attitudes we sought to measure 1) attitudes 
toward FGM/C as a practice, 2) attitudes to women who have experienced FGM/C and 3) 
attitudes towards families and communities that practice FGM/C. Attitudes toward the practice 
of FGM/C may include strongly negative attitudes such horror or disgust.23,24 Because FGM/C is 
not a normative practice in the USA, we conceived of the other end of the attitude spectrum as 
empathetic toward FGM/C rather than supportive or positive. We therefore also sought to 
include items to assess attitudes which may demonstrate that the provider understands that this 
practice may be meaningful and desired by the person who has undergone the FGM/C, their 
family or community.25   
We used a modified ecological framework as we conduct the psychometric analysis and 
validity testing of the new attitudes and confidence scales. An ecological framework posits that 
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any behavior must be understood in the context of individual, institutional, community, and 
societal factors. For this analysis, we focused on the individual, clinical training and clinical 
practice characteristics. Individual factors that may affect health care provider knowledge, 
attitudes, and practices for the care of those living with FGMC may include individual 
characteristics like their race or ethnicity, gender, and clinical degree. Factors related to clinical 
training include a clinical specialties related to women’s health, or having received training for 
FGM/C. Clinical practice characteristics may include if they care for women with FGM/C, or 
attend births.  
See figure #2. 
Figure 2 Factors Influencing the Health Care Provider Care for Those Living with FGM/C 
 
This study was further informed by the World Health Organization (WHO) framework 
elaborating the critical attributes that define quality care; it is effective, efficient, accessible, 
patient-centered, equitable, and safe.26 The operational definitions of each component of quality 
of care is provided in Table #1.  
Table 1 Dimensions of Quality of Care 
 
Effective Health care that is based on scientific knowledge and evidence-based guidelines 
Efficient Health care delivered in a manner that maximizes resource use and avoids waste 
Accessible Health care that is timely, geographically reasonable, and provided in a setting where skills and resources 
are appropriate to medical need 
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Safe Health care that minimizes risks and harm to service users, including avoiding preventable injuries and 
reducing medical errors 
Patient-
Centered 
Health care that takes into account the preferences and aspirations of individual service users and the 
cultures of their communities 
Equitable  Health care that does not vary in quality because of personal characteristics such as gender, race, ethnicity, 
geographical location, or socioeconomic status 
 
As we sought to conceptualize and study the knowledge, attitudes, and practices of health care 
providers caring for women and girls affected by FGM/C, we further explored how each of these 
aspects of quality of care were related to knowledge, attitudes and practices. See Figure #3. 
 
Figure 3 Knowledge, Attitudes and Practices for Quality Care 
 
 
We propose that knowledge for FGM/C care includes the cognitive awareness of the scientific 
and evidence-base content that contributes to care that is effective for improving the desired 
health outcomes of the patient. Practices for FGM/C care are those behaviors by the health care 
provider that demonstrate delivery of care that is efficient, accessible, and safe. Attitudes for 
FGM/C care would be those affective responses of the health care provider that affect the 
patient-centeredness or equity of either how care is delivered (practices) and/ or what care is 
offered (knowledge).  
The KAP framework has been used frequently to assess health care providers for the care 












measures for FGM/C.4 Existing studies assessing health care providers’ knowledge, attitudes, 
and practices do define these terms nor provider operational definitions of what constitutes these 
domains for FGM/C care. Existing studies typically report their results as purely descriptive, 
without exploring the relationships between knowledge, attitudes and practices or considering 
health care provider characteristics, such as demographics or past experiences with FGM/C, as 
confounders to these relationships.4,27 
FGM/C is a practice affecting approximately 200 million women and girls around the 
world, yet there are no validated instruments to assess health care providers caring for women 
affected by FGM/C, and there is a lack of formative research on the knowledge, attitudes and 
practices of health care providers that constitute quality care for those affected by FGM/C. 
Investigators tend to develop new instruments without conducting validation procedures, 
resulting in measures have notable gaps in terms of their conceptualization and content despite 
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Background: Approximately 545,000 women and girls living in the USA have either undergone 
Female Genital Mutilation/ Cutting (FGM/C) or have mothers from one of the FGM/C-practicing 
countries throughout Africa, the Middle East and South Asia. Health care provider attitudes 
towards the practice of FGM/C and confidence in their ability to address health needs related to 
FGM/C may affect the perceived quality of care by patients. However, there is currently no 
validated measure of provider attitude and confidence in the provision of care for patients with 
FGM/C. The lack of a validated measure limits our ability to assess health care provider attitudes 
and confidence, including the impact of trainings that aim to transform health care provider 
attitudes and confidence. 
 
Methods: We used a 3-stage instrument development process: 1) a systematic review of the 
FGM/C literature; 2) the development of attitude and confidence assessment items; and 3) an 
expert review and pre-testing of the developed measures. Next, we validated the instruments by 
piloting it among a diverse sample of health care providers in Arizona and Maryland. Finally, 
each subscale underwent psychometric validation using exploratory factor analysis to confirm 
factor structures.   
 
Results: We tested 13 attitudes and 11 confidence measurement items in this psychometric 
validation study. The exploratory factor analysis (EFA) revealed a two-factor solution for 
attitudes, including a scale for Negative Attitudes and Empathetic Attitudes toward FGM/C and 
those who practice FGM/C with Cronbach’s alpha coefficients of 0.814 and 0.628 respectively. 
The EFA for the confidence scales also revealed a two-factor solution including Confidence in 
Clinical FGM/C Care and Confidence in Critical Communication Skills for FGM/C Care with 
Cronbach’s alpha coefficients of 0.857 and 0.694 respectively. 
 
Discussion: FGM/C is a significant public health issue that health care providers are not 
adequately trained to address. Our study combines comprehensive review of the literature, expert 
opinion, and rigorous psychometric analysis to create a reliable and valid instrument to assess 












Female Genital Mutilation/ Cutting (FGM/C), a cultural practice with no health benefits, 
involves the cutting and/or removal of parts of the external female genitalia. According to 
UNICEF and the World Health Organization (WHO), FGM/C is practiced in certain 
communities across approximately 31 countries in Africa, the Middle East and South Asia, with 
its prevalence varying dramatically between and within countries.1,2 Motivations for the practice 
are diverse and may relate to beliefs about cleanliness, sexual norms, rites of passage, 
marriageability and/or group membership.27–29  The WHO has enumerated 33 possible health 
complications associated with FGM/C, which range from immediate post-FGM/C, physiological 
(obstetric, gynecologic, sexual) to psychological impacts.2 The WHO has classified FGM/C into 
four major types depending on the extent of tissue cut or removed and whether the vaginal 
opening is also narrowed. While all FGM/C types are associated with health complications, not 
everyone who has undergone FGM/C will experience them. Women with more extensive or 
severe cutting tend to have worse morbidity.14 In 2016 and 2018 respectively, the WHO 
published Guidelines on the Management of Health Complications from FGM and Care of 
Women and Girls Living with FGM: A Clinical Handbook which provide comprehensive 
guidance on the clinical care for those living with FGM.2,30  
Recent estimates from 2012 indicate that 545,000 women and girls living in the US may 
have either undergone FGM/C or were born to mothers from a country where FGM/C is 
practiced—an increase of 224% since 1990.31 As women and girls from families that practice 
FGM/C are born in or migrate to settings where the practice is non-normative, they may interact 
with healthcare providers who are unaware of FGM/C and who do not have the knowledge or 
confidence to provide evidence-based care. Even if a health care provider is confident in their 
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ability to provide quality care, they may hold attitudes that create barriers in the patient-provider 
relationship.24 When health care providers encounter a patient with FGM/C, they may experience 
a strong affective response from anger toward the practice of FGM/C to empathy for the women 
who experienced it.23 Challenges with cross-cultural communication can be further compromised 
for patients with low-English proficiency if the provider is not confident in their ability to 
conduct a visit via interpreter.32–34 Disagreements (such as whether to perform cesarean birth) 
and difficulties in communication can result in a lack of confidence in and distrust of providers 
by the patients.35,36 Some women with FGM/C prioritize minimizing interventions; this may be 
perceived by providers, who may not have actively listened to the patient’s perspective or 
priorities, as antagonist or ill-informed.37,38 Health care providers may experience frustration 
when patients express distrust or refuse recommended care.33 Women and girls who have 
experienced FGM/C deserve quality care, yet evidence suggests that they often do not receive 
it.37,39–42  
According to the WHO, quality care is effective, efficient, accessible, patient-centered, 
equitable, and safe.25 Current studies of health care providers and their patients affected by 
FGM/C show that FGM/C-related care is often ineffective and inequitable due to a lack of 
provider knowledge, training and confidence in their ability to provide appropriate care for 
FGM/C-related complaints.23,32,43  For example, a recent meta-synthesis of the birth experiences 
of FGM/C-affected women in the context of migration revealed anxiety and fear related to their 
pervasive perception that health care providers do not know how to care for them.37 Women with 
FGM/C often distrust health care providers who they feel lack the knowledge and confidence to 
provide high quality care for FMG/C related complaints.37,43–48 This distrust can result in women 
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with FGM/C being less likely to seek or access reproductive health care49 or to decline 
recommended care.33  
Effective care for women affected by FGM/C should be based on scientific knowledge 
and evidence-based guidelines.25  For example, an important intervention for women with Type 
3 FGM/C is defibulation, which is the surgical release of the scar covering the vaginal opening. 
Because of the lack of training in this technique, many obstetric providers in the USA lack the 
knowledge and confidence to adequately counsel women about this procedure or to perform it.50 
Providers who are knowledgeable about FGM/C have likely learned while caring for patients 
with FGM/C, rather than received training in advance.50,51 Experience caring for patients with 
FGM/C may impact the options offered to patients, including procedures like reinfibulation (the 
partial or complete re-closing of the infibulation scar after it has been defibulated), which some 
consider a form of FGM/C while others maintain adult women should be able to determine 
whether and to what extent the scar is reclosed.52 Clinicians with women’s health specialties and 
those with previous experience caring for those affected by FGM/C were more likely to report 
they would perform reinfibulation if asked by their patient as compared with providers without 
that expertise or those experiences.50 Though health care providers in the US may be unlikely to 
support FGM/C, they can demonstrate empathy for women who have undergone FGM/C through 
communication skills, such as active listening and non-judgmental responses, or through 
practices that demonstrate effective care, such as performing reinfibulation or discussing harm 
reduction strategies. Health care providers must be confident in their ability to provide quality 
care and to manage complex cultural and ethical discussions in order to promote the desired 
health outcomes of patients affected by FGM/C. 
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Existing Measures of Attitudes and Confidence for FGM/C-Related Care 
Health care provider attitudes and confidence impact the quality of care received by 
patients affected by FGM/C, yet there are few existing instruments to measure these constructs. 
Existing measures are characterized by the lack of psychometric assessments to determine their 
reliability or validity. Authors use no53,54 or limited validation procedures including expert 
review55–57 and pre-testing.50,55,56,58,59 These measures lack conceptual definitions of attitudes and 
confidence and do not explain the rationale for item selection.  
To inform a new measure, we reviewed existing measures of attitudes created for use in 
high resource countries where FGM/C is not normative to inform our own measure. We selected 
a working definition of attitudes to inform our review and instrument development. Attitudes are 
the expression of an individual’s tendency of favor or disfavor expressed toward a particular 
entity.22 Existing measures tend to include items that focus on ethical issues related to FGM/C 
(e.g., whether adult women have the right to elect FGM/C or whether the respondent considers 
FGM/C a violation of human rights and/or a form of violence against women), which may 
provide insight into how providers respond to patients with FGM/C and what types of treatments 
are offered. 7,50,58,60 The items assessing attitudes towards ethical issues tended to have agree/ 
disagree Likert scale type responses.  Endorsement of items related to the rights of women and 
families to choose FGM/C for themselves or their daughters may give some indication of a 
provider’s intention to engage in these practices or support someone who elects to do so. In 
addition, they may indicate health care provider empathy, or willingness to see the patients’ 
perspective in terms of what FGM/C means to her and her family. Other items included in 
existing attitudes measures are more accurately described as knowledge (e.g., whether FGM/C is 
a religious or cultural practice), or contextual questions (e.g., whether FGM/C is legal in their 
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jurisdiction, mandatory child protective services reporting requirements, awareness of intentions 
to cut a girl child in the community or by traveling abroad [vacation-cutting]).60 Additional 
attitudes items asked respondents to state how they would respond to a patient affected by 
FGM/C.10 However, these types of items should be considered outcome variables that are 
influenced by attitudes, rather than attitude measuring items. For example, a health care provider 
might be more likely to report the patient to the authorities if they view FGM/C as a crime.  
Existing measures of attitudes tend to focus on attitudes toward FGM/C as a practice, 
rather than attitudes towards the women, girls, and communities that are affected by or support 
FGM/C. Negative attitudes toward those affected by FGM/C are important to measure because a 
health care provider’s negative attitude toward a person on the basis of irrelevant characteristics 
such as race or language proficiency (also known as implicit bias) has been shown to negatively 
affect clinical care including diagnosis, treatment decisions, health outcomes, non-verbal 
behaviors, and patient-provider interactions.61,62 Most women and girls affected by FGM/C in the 
USA are of African, Asian or Middle Eastern descent – groups where 50-75% of individuals 
surveyed report experiencing bias or discrimination in the health care setting.62,63 They also 
report reduced experiences of bias when they have a health care provider who shares their racial 
or ethnic identity.62,64 Women and girls who have experienced FGM/C embody multiple 
identities that, within the USA, can render them vulnerable to bias and discrimination including 
immigration/ refugee status, low-English proficiency, and being a person of color.24,61,65  
 Few measures assess health care provider confidence for the care of women and girls 
affected by FGM/C. During our review, we identified only two studies since 2007 that assessed 
health care provider confidence. Both measures have notable limitations, including the lack of a 
conceptual definition of confidence and no operational definition to explain the rationale behind 
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item development.54,57 Self-reported confidence in a particular skill is also termed self-efficacy 
and can explain, in part, the actual performance of that skill.66 Self-efficacy is the perceived 
capability to perform a behavior and is a robust predictor of whether someone will engage in a 
target behavior.67 Their main limitation of one study is that the items encompassed multiple 
concepts, thereby limiting score interpretability as it is unclear as to which aspect of the item 
respondents considered in their responses.54 Despite limitations, many concepts were important 
to consider for our measure including confidence for discussing defibulation, to identify and 
manage FGM/C, documentation, and counseling.54,57 
Existing measures of health care provider attitudes and confidence provide some insights 
into challenges of providing FGM/C related care, and what types of attitudes health care 
providers hold. The current literature on health care provider attitudes and confidence would be 
strengthened by measures that utilize clear conceptual definitions of attitudes and confidence, 
that hypothesize relationships between attitudes and confidence, have undergone psychometric 
testing, and that enable researchers to explore the relationships between attitudes, confidence, 
and other provider characteristics. In this study, we describe the development and psychometric 
assessment of novel measures of attitudes and confidence of health care providers caring for 
women and girls affected by FGM/C. The Health Care Providers Attitudes Toward FGM/C and 
Those Who Practice FGM/C scale captures providers’ empathetic and negative attitudes. The 
Health Care Providence Confidence for FGM/C scale assesses health care providers confidence 
in providing care for and communicating with women and girls affected by FGM/C. Our 
instruments can be used to understand provider attitudes and confidence about FGM/C before 
and after trainings to generate a baseline understanding of these competencies and allowing for 
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comparisons between providers in different settings. This information can also be used to 




We drafted the items for the attitudes and confidence scales following an exploration of 
the qualitative literature addressing patient experiences receiving care and health provider 
experiences providing care related to FGM/C. Authors CM (Nurse-Midwife) and CJA 
(OB/GYN) discussed the attitudes- and confidence-related domains that emerged from the 
literature review and considered their own experiences providing care for patients affected by 
FGM/C. We sought to develop attitude items that may affect quality of care for patients who 
have experienced FGM/C including negative and empathetic attitudes toward FGM/C, and those 
affected by the practice. Negative attitudes include attitudes held by the health care provider that 
might lead them to express, or a patient to experience, discrimination or bias related to their 
FGM/C status. Empathetic attitudes include attitudes that might lead the health care provider to 
prioritize a patient-centered approach to FGM/C-related care. We also included items assessing 
possible support for medicalization or a harm reduction approach to FGM/C in our empathetic 
attitudes measure.   
We determined that there were broadly two areas of confidence that directly influenced 
the effectiveness, and equitable patient-centered delivery of care to patients affected by FGM/C: 
confidence for the provision of clinical care, and confidence in the ability to communicate 
effectively. Ideally, we would directly observe provider care; however, given the ethical and 
practical challenges, self-reported confidence is used as a proxy measure. We developed the 
confidence measure to assess confidence for clinical care and communication and aligned them 
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with key components of a provider-patient encounter. Items related to clinical care included 
gathering subjective and objective data, making an assessment, and developing a patient-
centered treatment plan. Specifically, for patients affected by FGM/C, this would include 
identifying FGM/C, determining its type, documenting its presence, and discussing potential 
complications and their management.  Critical communication skills for care of patients affected 
by FGM/C include the ability to effectively conduct visits via an interpreter, provide evidence-
based treatment options, maintain rapport with a patient who is declining recommended care, 
engage in non-judgmental listening and shared-decision-making.  
 
Expert Review and Pre-Testing 
Clinical FGM/C experts including an obstetrician/ gynecologist, a nurse-midwife, and a 
pelvic floor physical therapist reviewed the thirteen attitudes and eleven confidence items for 
content validity. We circulated a shared document adding comments and edits that were 
integrated by CM. Comments included grammatical adjustment, clarifying wording to avoid 
jargon, and simplifying sentence structure. One attitudes item was dropped because it contained 
multiple clauses and was thus responses were not interpretable. No other items were added or 
dropped. Next, a nurse-midwife and medical resident who are not FGM/C experts reviewed the 
instrument for clarity and understandability while seated with CM. CM inquired what they 
thought each question was intending to ask to ensure that their interpretation was consistent with 
our intention.  No issues arose during this review, and no further revisions were suggested. The 
survey was then pre-tested among a convenience sample of 3 medical students, 2 medical 
residents, and 2 nurse-midwives with no previous FGM/C-related training in current clinical 
 25 
practice in the Phoenix and Baltimore-DC areas. The full survey took approximately 7-10 
minutes to complete. No further edits were suggested by the pilot testers.  
 
Study Setting 
We conducted an online cross-sectional survey of health care providers at the time of 
registration in a workshop titled “Optimizing Care for Women and Girls Affected by FGM/C” in 
the greater Phoenix and Tucson, Arizona and Baltimore, Maryland areas. This workshop and 
study were conducted as part of a multi-phase study that aimed to identify and address gaps in 
care for women and girls affected by Female Genital Mutilation/Cutting (FGM/C).  
 
Recruitment and Study Population 
Health care providers were invited to register for the workshop and complete the survey 
via emails that were distributed to list-servs at 14 health care institutions in Phoenix and Tucson, 
Arizona metropolitan areas. Arizona List-servs included between 80-400 contacts. The survey 
was broadly distributed within the Johns Hopkins Health System and Johns Hopkins University 
Schools of Medicine, Nursing and Public Health as well as to professional organizations in the 
greater Baltimore, Maryland and Washington D.C. area. The primary list-serv contacts included 
nursing and residency training program directors, medical directors, nursing and medical faculty, 
and hospital department chairs, and points of contact for local chapters of professional 
organizations such as AWHONN, ACNM, and ACOG.  
The study population included health care providers who registered for the workshop and 
completed the online survey at the time of registration. A broad sample of health care providers 
registered for the workshop and completed the baseline survey, including physicians, residents, 
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nurses, nurse-practitioners, nurse-midwives, physicians assistants, mental health workers, social 
workers, and students in the health professions.   
 
Measures  
The survey included demographic and scope of clinical practice questions, as well as 
items to assess previous FGM/C related clinical experiences and familiarity with FGM/C 
terminology and procedures. The Health Care Providers Attitudes Toward FGM/C and Those 
Who Practice FGM/C scale included twelve items total, with five that assessed negative and 
seven items that assessed empathetic attitudes toward FGM/C, communities and families that 
support FGM/C, and women who have experienced FGM/C. See table #2 for all Attitude items. 
The Health Care Providence Confidence for FGM/C Care measure included five items that 
assessed key aspects of clinical care for women and girls who have undergone FGM/C including: 
FGM/C case and type identification, documentation of FGM/C care using appropriate codes, 
interpreter use, and provision of counseling regarding health complications of FGM/C. The 
remaining three items assessed confidence in critical communication skills for FGM/C care, 
including those related to listening, counseling, and interpreter use. See Table #3 for all 
confidence items. For both the Attitudes and Confidence scales, participants were asked to read 
each statement and then mark their level of agreement with the given statements on a four-point 
Likert-scale from “4=Strongly Agree” to “1=Strongly Disagree.”   
 
Table 2 Health Care Providers Attitudes - Items 
  
 Negative Attitudes Toward FGM/C and Those Who Practice FGM/C 
1 FGM/C is a violation of human rights  
2 Communities that practice FGM/C are oppressive towards women.   
3 Health Care Providers who perform any form of FGM/C, including symbolic nicking, should be charged with a crime.  
4 Parents who have their daughter circumcised are abusing them. 
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5 Women who have undergone FGM/C are victims of an oppressive cultural practice.   
 Empathetic Attitudes Toward FGM/C and Those Who Practice FGM/C 
6 Symbolic nicking or cutting of the female genitalia is an effective way to reduce the harm of FGM/C compared to more 
extensive procedures.   
7 Communities that practice FGM/C are honoring an important cultural tradition.  
8 Adult women have the right to undergo FGM/C.  
9 Parents who have their daughter circumcised are protecting her future marriage prospects.   
10 Women who have undergone FGM/C are empowered agents.  
11 Parents have the right to have their daughters circumcised (undergo FGM/C).  
12 Health care providers should perform reinfibulation (re-closing of the vulvar scar following childbirth) if the woman 
requests it.  
 
 
Table 3 Health Care Provider Confidence - Items 
 
1 On inspection of the female genitalia, I can identify a woman with FGM/C  
2 On identification of a woman with FGM/C, I can assign the appropriate WHO Type classification   
3 On identification of a woman with FGM/C, I can appropriately code a visit to document the presence and type of FGM/C 
using ICD-10 and CPT codes  
4 Conduct an effective reproductive/sexual health history via an interpreter  
5 Respond to the health concerns of women with FGM/C by engaging in non-judgmental listening  
6 Counsel women on the possible complications she may experience related to FGM/C  
7 Discuss defibulation with pregnant women who have undergone Type 3 FGM/C in a culturally sensitive manner  
8 Create a positive therapeutic relationship with a patient who refuses a recommended procedure  
 
For both the Attitudes and Confidence scales, participants were asked to rate their agreement 




We used SPSS version 26. We examined construct validity for each scale using 
exploratory factor analysis (EFA) with principal axis factoring and oblimin rotation. Factor 
loadings above 0.40 were considered as loading on a given factor, and those below were 
considered for revision or elimination from the scale. We reviewed the items loading on each 
factor to ensure they comprised interpretable constructs and distinct subscales. We used 
Cronbach’s alpha to assess the internal consistency reliability for each subscale.  
 28 
We assessed validity by comparing known groups using independent t-tests; p-values 
<0.05 were considered significant. For the attitude scales, we tested the a priori hypotheses that 
health care providers 1) with previous FGM/C training; 2) who have ever cared for a patient 
affected by FGM/C; 3) who identify as nurses, social workers, or mental health specialists; 4) 
whose clinical practice focuses on women’s health; 4) who are of color; and 6) who are women 
will have less negative attitudes and more empathetic attitudes toward FGM/C and those who 
have experienced FGM/C. For the confidence scale, we tested the a priori hypotheses that those 
1) who have had previous FGM/C training; 2) who have cared for a patient affected by FGM/C; 
and 3) whose clinical practice focuses on women’s health will have greater confidence for the 
care of those affected by FGM/C.  
Results 
Enrollment and Participant Characteristics 
A total of 796 individuals attended training events in Arizona and 101 in Maryland for 
897 possible survey participants. A total of 369 participants initiated the online survey, of whom 
14 did not provide any responses following the informed consent screen. The remaining 354 
participants completed the online survey for a response rate of 39.5%. Exploratory factor 
analysis requires that all participants have completed all items to be included in the analysis. For 
the Attitudes scale, 291 (82.2%) participants completed all items and were included in the EFA. 
For the Confidence scale, we limited analysis to health care providers who are licensed 
independent providers, defined as physician or an individual licensed and authorized to write 
medical orders to provide care for a patient, and thus able to provide the outpatient medical care 
that Confidence scale items address (n=169, 47.7% of the total sample) including physicians and 
medical residents (MD), midwives (CNM), and nurse practitioners (NP) of whom n=143 
 29 
(84.6%) completed all Confidence items. There were no significant differences in any participant 
characteristics between completers and non-completers. Participants for the total sample were 
predominantly female (81.4%), white (67.5%), and had a clinical specialty outside of women’s 
health (65.0%). Demographics were similar for the attitudes and confidence sub-groups; 
however, among the sample for the confidence scale more participants were white (77.6%) and 
had a women’s health focus in their clinical practice (52.4%). See table #4 for detailed 
participant characteristics 
 
Table 4 Participant Characteristics 
   
 All Health Care Providers 
Attitudes EFA**  
(n=291) 
Licensed Independent 
Providers Only  
Confidence EFA** 
(N= 143) 
 N (%) N (%) 
Gender   
- Female 240 (82.5) 108 (75.5) 
- Male 37 (12.7) 28 (19.6) 
- Missing/ Declined/ Other 14 (4.8) 7 (4.9) 
Race/ Ethnicity   
- Person of Color 97 (33.3) 33 (23.1) 
- Black/ African American 30 (10.3) 8 (5.6) 
- Asian 31 (10.7) 15 (10.5) 
- Latino/ Hispanic; Native American; Other (non-
white)* 
35 (12.0) 10 (6.8) 
- White  194 (66.7) 109 (76.2) 
Clinical Practice   
- Licensed Independent Provider 138 (47.4)  
- Resident 70 (24.1) 72 (50.3) 
- Physician 38 (13.1) 37 (25.9) 
- CNM 22 (7.9) 25 (17.5) 
- NP 8 (3.4) 9 (6.3) 
- Other Health Care Provider 153 (52.6) -- 
- RN 38 (13.1) -- 
- Social Work 9 (3.1) -- 
- Mental Health 8 (2.7) -- 
- Student 72 (24.7) -- 
- Other/ Missing 11 (6.2) -- 
Women’s Health Specialty   
- Yes 86 (29.6) 74 (51.7) 
- No 189 (64.9) 62 (43.4) 
- Missing 16 (5.5) 7 (4.9) 
Scope of Practice includes BIRTH (Ob/Gyn, Midwife)   
- Yes 67 (23.0) 73 (51.0) 
- No 208 (71.5) 63 (44.1) 
- Missing 16 (5.5) 7 (4.9) 
*Due to small sample size for these demographic groups, they were combined to protect participant privacy.  
**Demographics for participants who completed all items for the respective scale.  
 30 
 
In terms of clinical experiences related to FGM/C, among the full sample of health care 
providers fewer than half have ever cared for a woman or girl who had experienced FGM/C 
(44.0%), though among licensed independent health care providers two-thirds had cared for 
someone who had experienced FGM/C (69.4%). Most participants had not received any formal 
training regarding FGM/C. Among licensed independent health care providers, most were aware 
of defibulation (68.7%) and the WHO FGM/C Type system (59.59%). Only about one-tenth of 
obstetric health care providers (Ob/Gyns and Midwives) had been trained to perform defibulation 
(11.9%). See table #5 for additional details about the FGM/C related clinical experiences of the 
participants. 
Table 5 FGM/C Clinical Experiences 
 
 Attitudes EFA 
All Health Care Providers  
(n=291) 
Confidence EFA 
Licensed Independent Providers Only  
(N= 143) 



























OB/ GYN and Midwives* (n=67)  









*Participants for whom defibulation is within their scope of practice  
 
Results – Psychometric Testing for Attitudes 
We began the exploratory factor analysis by reviewing the cases for completeness which 
demonstrated 3-9.9% missing responses per item. No items were eliminated due to missingness. 
We reviewed the variance of each item and eliminated one item because it had minimal variance 
with greater than 93% responding either disagree/ strongly disagree (Parents have the right to 
have their daughters circumcised (undergo FGM/C)). The lack of variance in this item may be 
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because FGM/C is commonly considered a violation of human rights in the USA. The 
eigenvalues (first 5 were 3.72, 1.39, 1.07, 1.03, 0.84) suggested that the 11 items formed two 
factors, which we confirmed using a scree plot visualization to identify the two factors above the 
break in the plot. See figure #4 for the Scree Plot. 
Figure 4 Scree Plot - Attitudes 
 
 
All factor loadings were above 0.400 on only one of the two-factors except for Women who have 
undergone FGM/C are empowered agents which had a factor loading of 0.390 and was retained 
for the final subscale. The two-factor solution accounted for 37.5% of the total variance. Each 
item loaded cleanly on one of the two factors, except for Health care providers should perform 
reinfibulation (re-closing of the vulvar scar following childbirth) if the woman requests it which 
did not load on either factor and thus was dropped. This item likely did not perform well in the 
EFA because many participants may be unfamiliar with the term reinfibulation. See table #6 for 
the rotated factor loadings for the Attitudes items. 
Items loaded according to whether they addressed negative or empathetic attitudes 
toward FGM/C and those who practice or are affected by FGM/C including the women 
themselves, their families and communities (further referred to as Negative Attitudes and 
Empathetic Attitudes for brevity). The scale names aim to highlight that health care providers 
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toward FGM/C and the individuals who have undergone FGM/C or perpetuate the practice 
within families or communities can affect the care that is provided. Each subscale has five items. 
The correlation between the factors is -0.558 which indicates that the factors have a strong 
correlation but represent distinct underlying variables that are inversely correlated. The 
communalities for all items range from 0.173 - 0.624.  
 
Table 6 Rotated Factor Loadings – Attitudes Items 
 
 Negative Attitudes Toward 
FGM/C and Those Who 
Practice FGM/C 
Empathetic Attitudes Toward 
FGM/C and Those Who 
Practice FGM/C  
FGM/C is a violation of human rights .593 -.066 
Health Care Providers who perform any form of FGM/C, 
including symbolic nicking, should be charged with a 
crime 
.455 -.099 
Communities that practice FGM/C are oppressive 
towards women 
.809 .101 
Parents who have their daughter circumcised are abusing 
them 
.804 .039 
Women who have undergone FGM/C are victims of an 
oppressive cultural practice 
.766 -.041 
Symbolic nicking or cutting of the female genitalia is an 
effective way to reduce the harm of FGM/C compared to 
more extensive procedures 
.024 .444 
Adult women have the right to undergo FGM/C -.025 .440 
Communities that practice FGM/C are honoring an 
important cultural tradition 
-.028 .557 
Parents who have their daughter circumcised are 
protecting her future marriage prospects 
.043 .637 
Women who have undergone FGM/C are empowered 
agents 
-.044 .390 
Cronbach’s Alpha 0.814 0.628 
DROPPED ITEM 
Health care providers should perform reinfibulation (re-
closing of the vulvar scar following childbirth) if the 





Principal Axis Factoring. Rotation Method: Oblimin Rotation.  
 
Reliability 
We assessed the reliability of the subscales using Cronbach’s alpha – a measure of 
internal consistency of the items as they perform in a specific sample. The Empathetic Attitudes 
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subscale has a Cronbach’s alpha of 0.628. This meets the 0.60 threshold considered the 
minimum acceptable for early stages of research.68,69 Further, Cronbach’s alpha tends to 
underestimate the internal consistency of scales with fewer than 10 items such as ours.70,71 The 
Negative Attitudes subscale has a Cronbach’s alpha of 0.814 which is considered an acceptable 
level of internal consistency. 
 
Descriptive Statistics 
We calculated total scores for each subscale by summing scores for each of the five 
items. Higher scores indicate more negative attitudes and more empathetic attitudes on each 
scale respectively. See table #7 for means, standard deviations, minimum and maximum 
observed scores 
 
Table 7 Attitudes - Descriptive Statistics 
(n=291) 
 Mean  Std. Dev. Min Max Possible 
Range 
Negative Attitudes Toward FGM/C  15.85 2.65 10 20 5-20 
Empathetic Attitudes Towards FGM/C 11.75 2.37 5 20 5-20 
 
The mean score on the Negative Attitudes was 15.85 (SD 2.65) out of 20 indicating that the 
sample tended to agree or agree strongly with statements that portray FGM/C and those who 
practice FGM/C negatively. The range of scores for the Negative Attitudes subscale was between 
10-20 with a roughly normal distribution of scores. The mean score on the Empathetic Attitudes 
was closer to the mid-range of possible scores (11.75, SD 2.37) indicating that participants 
tended to agree or disagree with the statements, rather than holding strong opinions on either end 
of the response range. The range of scores for participants on the Empathetic Attitudes subscale 




We assessed criterion validity using independent t-tests to assess hypothesized 
differences in scores between known groups. There were no significant differences in scores on 
the Negative Attitudes or Empathetic Attitudes scales between those who had received training or 
ever care for patient with FGM/C compared to those without those experiences. Licensed 
independent providers (MD/ CNM/ NP) had significantly higher scores on the Negative Attitudes 
scale and significantly lower scores on the Empathetic Attitudes scale compared with nurses and 
mental health providers which supports our hypothesis. Scores were not significantly different on 
either scale for participants with a clinical focus in women’s health. Male participants and white 
participants both had significantly higher scores on the Negative attitudes scale which supports 
our hypotheses; however, there were no significant differences in scores on the Empathetic 
Attitudes scale for either of these two groups. See table #8 for details criterion validity analysis. 
 
Table 8 Criterion Validity – Attitudes 
(n=291) 
 Negative Attitudes Empathetic Attitudes 
 N Mean (SD) p  Mean (SD) p  
PREVIOUS FGM/C EXPERIENCES 
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Results – Psychometric Testing for Confidence Scale 
The psychometric analysis of the Confidence scale includes licensed independent 
providers (doctors, residents, midwives, and nurse-practitioners). We began the factor analysis 
by reviewing the cases for completeness which demonstrated 4-9% missing responses per item. 
We reviewed the item variance and found that Respond to the health concerns of women with 
FGM/C by engaging in non-judgmental listening and Create a positive therapeutic relationship 
with a patient who refuses a recommended procedure had minimal variance with >91% selecting 
agree or strongly agree. We retained these items for the EFA because they addressed important 
aspects of quality care related to communication with women and girls who have experienced 
FGM/C.  
The EFA resulted in a 2-factor solution, which accounted for 50.87% of all variance. The 
eigenvalues (first five were 3.64, 1.21, 0.84, 0.70, 0.55) suggested that the eight items form two 
factors, which we confirmed using the scree plot to visualize two factors above the break in the 
plot. See Figure #5.  
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Figure 5 Scree Plot - Confidence 
 
All items had factor loadings over 0.400 and each item loaded on a single factor. See table #9 for 
rotated factor loadings for the confidence items. The communalities range from 0.223 – 0.823.  
Table 9 Rotated Factor Loadings – Confidence Items  
 
 Confidence in 
Clinical FGM/C 
Care  
Confidence in Critical 
Communication Skills for 
FGM/C Care 
On inspection of the female genitalia, I can identify a woman 
with FGM/C 
.569 0.166 
On identification of a woman with FGM/C, I can assign the 
appropriate WHO Type classification  
.970 -0.185 
On identification of a woman with FGM/C, I can appropriately 
code a visit to document the presence and type of FGM/C using 
ICD-10 and CPT codes 
.736 -0.064 
Counsel women on the possible complications she may 
experience related to FGM/C 
.512 0.380 
Discuss defibulation with pregnant women who have undergone 
Type 3 FGM/C in a culturally sensitive manner 
.695 0.183 
Conduct an effective reproductive/sexual health history via an 
interpreter 
0.285 .463 
Respond to the health concerns of women with FGM/C by 
engaging in non-judgmental listening 
0.080 .747 
Create a positive therapeutic relationship with a patient who is 
refuses a recommended procedure 
-0.094 .670 
Cronbach’s Alpha 0.857 0.694 
Principal Axis Factoring. Rotation Method: Oblimin Rotation.   
 
The first subscale addresses items related the provision of clinical care of women who have 
experienced FGM/C, titled “Confidence for Clinical FGM/C Care.” The second subscale 
includes items that assess the health care provider’s confidence in critical communication skills 
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for the care of women who have experienced FGM/C titled “Confidence in Critical 
Communication for FGM/C.”  
 
Reliability 
The Cronbach’s alpha coefficient for the two confidence subscales were 0.857 for the 
“Confidence in Clinical FGM/C Care” and 0.694 for “Confidence in Critical Communication 
Skills for FGM/C Care” again indicating acceptable levels of reliability.  
 
Descriptive Statistics 
We calculated scores for the subscales by summing the scores for each item. The 
subscale “Confidence in Clinical FGM/C Care” has five items on a four-point Likert scale from 
strongly disagree=1 to strongly agree=4 for a possible score range of 5-20. The subscale 
addressing “Confidence in Critical Communication Skills for FGM/C Care” has three items on 
the same four-point Likert scale for a possible range of 3-12. Higher scores indicate more 
confidence. The correlation between the two factors is 0.461 which indicates that the subscales 
are positively correlated but do measure distinct latent constructs. See table #10 for descriptive 
statistics. 
 
Table 10 Descriptive Statistics – Confidence Scales 
(n=143) 
 Mean Std. Dev. Range (possible) Min Max 
Confidence in Clinical FGM/C Care 11.52 2.90 5-20 5 20 
Confidence in Critical Communication 
Skills for FGM/C Care  
9.08 1.35 3-12 3 10 
 
The mean score on the Clinical FGM/C Care subscale (11.52) indicating that participants 
generally endorsed a moderate level of confidence in their ability to provide clinical care for 
women and girls affected by FGM/C. The distribution of scores on the Clinical FGM/C Care 
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subscale is approximately normally distributed with slightly more participants reporting lower 
levels of confidence. The mean score on the Critical Communication Skills for FGM/C Care 
subscale (9.08) indicates somewhat higher confidence in communication skills compared to 
clinical skills for FGM/C. The distribution of scores for the Critical Communication Skills for 
FGM/C Care scores is approximately normally distributed.  
 
Criterion Validity – Confidence Scales 
We assessed criterion validity using independent t-tests to assess differences in scores 
between known groups. Health care providers who had ever cared for someone affected by 
FGM/C, had ever received FGM/C training, whose scope of practice includes a women’s health 
specialty, people of color, and women rated their Confidence in Clinical FGM/C Care 
significantly higher than the comparison groups. Health care providers who have ever cared 
someone who had experienced FGM/C and those with a scope of practice focused on women’s 
health had significantly high scores on the Confidence in Critical Communication Skills for 
FGM/C Care scales than the comparison groups. There was no significant difference in 
Confidence in Critical Communication scores for those who had received previous training 
related to FGM/C. See table #11. 
 
Table 11 Criterion Validity – Confidence Subscales 
(n=143) 
 Confidence in Clinical FGM/C Care Confidence in Critical 
Communication Skills for FGM/C 
Care 
 N Mean (SD) p  Mean (SD) p  
PREVIOUS FGM/C EXPERIENCES 






































SCOPE OF PRACTICE 
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*Statistically Significant <0.05 
 
Discussion 
In this study, we have constructed measures of health care provider attitudes and 
confidence for the care of women and girls affected by FGM/C and assessed their validity and 
reliability. Our new measures of health care provider attitudes and confidence for the care of 
FGM/C-affected patients represent an important step forward in the assessment of health care 
providers. We utilized a conceptual approach to our item development by first defining attitudes 
and confidence, and then framing which types of attitudes (negative and empathetic), and 
confidence (clinical skills and communications skills) were important when considering their 
effect on quality of care based on review of qualitative studies and existing measures. Our 
attitudes scales include some items that are similar to existing measures (harm reduction, adult 
women’s right to FGM/C, human rights) and add novel items to assess attitudes towards 
communities that practice FGM/C and affected patients.  
The psychometric properties of the Confidence subscales were strong overall. The 
subscales have a clear factor structure, and acceptable reliability. The validity of the Confidence 
for Clinical FGM/C Care is supported by the significance of the hypothesized group differences. 
The validity for the Confidence in Critical Communication Skills for FGM/C Care is supported 
by the significance of two of three hypothesized group differences. While we did not find a 
significant difference in confidence scores for those with and without previous FGM/C training 
in the Confidence in Communication subscale, this could potentially be a result of training 
programs focusing more on clinical skills than communication skills. There is very limited 
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published data on existing trainings for FGM/C, and none we reviewed evaluated training 
effectiveness to improve communication skills.  
The Attitudes subscales also have clear factor structures, and the reliability of the 
Negative Attitudes subscale is acceptable. The reliability of the Empathetic Attitudes subscale 
falls just below the acceptable threshold. Cronbach’s alpha measures have some limitations -they 
measure the internal consistency of the items within a specific sample, where more heterogenous 
populations tending to increase the Cronbach’s alpha. Given that our sample was self-selected, 
they may be more homogenous and positive in terms of attitudes toward FGM/C compared to the 
general population of health care providers. Our subscales also have a relatively small number of 
items (<10), which can also lower the alpha estimate. The reliability of the scales should be 
further assessed in a random sample of health care providers. Future research should further 
assess the reliability of these scales with a diverse study population that varies in relation to 
demographic variables such as race, gender, and political affiliation; travel experience; and 
whether FGM/C has been practiced within their family or close contacts. Further validation of 
the scale could also include assessment of concurrent validity. Though there are no validated 
measures of attitudes related to FGM/C, comparing participants’ scores on our scale with scores 
on validated measures of empathy and implicit bias may further inform the validity of the 
attitude scales.  
There are some important differences between our scale and existing measures. We did 
not include items that assessed whether participants believe FGM/C is a religious practice or 
whether they knew their legal or reporting requirements because these questions address 
knowledge rather than attitudes.7,60 Our confidence scales included some similar concepts 
compared to existing measures including items addressing identification and documentation of 
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FGM/C; however, our scales included more items regarding communication and counseling 
skills.54,57 Our scales are consistent with existing measures for attitudes and confidence by 
including items about defibulation and reinfibulation.50,54,58   
Within the US, many women and girls affected by FGM/C are migrants or refugees from 
Africa, Asia, or the Middle East who may have low-English proficiency – all variables that may 
contribute to experiences of bias, discrimination, and lower quality of care. The historical legacy 
of slavery and racism in the US, and in particular the “othering” of African women’s bodies, may 
implicitly influence the patient-provider interaction, counseling and decision-making.24 Health 
care providers must take responsibility for communicating attitudes that promote positive 
patient/provider interaction so that FGM/C affected patients do not experience bias or 
discrimination during a clinical encounter. Our scales are an important step to assess health care 
provider attitudes toward FGM/C and those affected by the practice, and eventually to explore 
how their attitudes are related to patient experiences of care. The new attitudes scales may allow 
researchers and educators to explore whether health care providers who experience more 
empathic and less negative attitudes provide higher quality care to patients affected by FGM/C. 
While empathy does tend to improve patient-provider communication, it is important to assess if 
health care provider empathy moves toward endorsement of harm reduction approaches to 
addressing FGM/C versus elimination of the practice.72 Some health care providers maintain that 
the less extensive forms of FGM/C, such as symbolic nicking, should be permitted in place of 
more extensive cutting to minimize harm.72–74 A recent case in Michigan where a doctor 
allegedly performed type 1 FGM/C in a clinic illustrates that FGM/C diaspora communities and 
health care providers are negotiating these tensions within the US.75 By including items that 
assess strongly empathetic attitudes toward FGM/C, researchers and educators may be able to 
 42 
provide additional education to health care providers regarding the physical and ethical harm of 
cutting the genital of a minor. Some argue that minors (child with male, female, or intersex 
genitalia) must be protected from bodily harm, which includes nontherapeutic genital surgery or 
cutting (including male circumcision).76 Though these attitudes may be less common in the US, 
our scales may detect the range of empathetic attitudes. It is important to note that this measure 
assesses attitudes, and not intent. 
In our study sample, previous training in FGM/C was not a statistically significant 
predictor of increased Confidence in Communication for FGM/C. This may be because existing 
FGM/C trainings do not focus on communication skills, or if they do, may not provide an 
opportunity to practice those skills in order to measurably improve provider confidence.77  Future 
trainings should include informational content about FGM/C (history and context, identification, 
documentation, complications, and management for patients affected by FGM/C) to build 
provider confidence in their knowledge to provide clinical care for FGM/C. Trainings should 
include opportunities for simulation, reflection, and engagement to practice applying knowledge,  
communications skills (including interpreter use), and build awareness of how their attitudes 
may affect the quality of care delivered to those affected by FGM/C.75 Broad health workforce 
education to improve the care of patients affected by FGM/C, including effective evaluation of 
education and training interventions, is an important public health priority.75 
 Some limitations of our study include geographic restriction of the study population to 
the greater Phoenix, Tucson, and Baltimore areas and a low response rate by the study 
population. We used a convenience sample for this analysis with participants who self-selected 
to register and complete the survey for an FGM/C training workshop, which could result in a 
bias related to their interest in the topic of FGM/C. Future studies may expand the geographical 
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area of the study population and different recruiting methods to reduce bias.  As discussed 
previously, the Empathetic Attitudes subscale did not have strong reliability as measured by 
Cronbach’s alpha. A future iteration of the Empathetic Attitudes scale with additional items in a 
random sample of health care providers may remedy this issue. Our study could have been 
strengthened by assessing concurrent validity of our subscale using a criterion measure; 
however, we were not able to identify any validated attitudes or confidence scales to use.  
 
Conclusion 
To the best of our knowledge, our attitude and confidence scales presented here are the 
first psychometrically validated measures to assess health care provider attitudes and confidence 
in the care of women and girls affected by FGM/C. Our confidence scales have strong validity 
and reliability, our attitudes scales have a clear factor structure, and the Negative Attitudes scale 
has strong reliability. Researchers may explore the relationship between health care provider 
attitudes and confidence for FGM/C related care with patient outcomes such as patient 
perceptions of quality of care (including experiences stigma and/or bias), trust in their provider, 
and receipt of appropriate diagnosis and treatment of FGM/C and associated health 
complications. Our measures will support future researchers to investigate factors that affect 
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Background: Health care providers in the USA often lack awareness about FGM/C and its 
complications, lack confidence in their ability to provide appropriate FGM/C-related care, and 
experience attitudes towards FGM/C that may negatively impact quality of care. Women 
affected by FGM/C receiving care in the diaspora are aware of these deficits which result in a 
distrust of health care providers, and fear and anxiety accessing the health care system. Women 
affected by FGM/C report experiencing stigma and bias related to their FGM/C status.  
 
Methods: We conducted a cross-sectional baseline survey of health care providers in Phoenix 
and Tucson, Arizona and Baltimore, Maryland areas. Following a summary of descriptive 
statistics of demographics and previous FGM/C-related clinical experience, we performed 
multivariable analysis to explore the associations between health care provider awareness of 
health complications of FGM/C, and scales on validated measures for Confidence for Clinical 
FGM/C Care, Confidence in Critical Communication Skills for FGM/C Care, Negative Attitudes 
toward FGM/C and Empathetic Attitudes Toward FGM/C.  
 
Results: Health care providers were aware of a median of 25 of 33 health complications 
associated with FGM/C. Factors associated with increased awareness of health complications 
included having ever care for a woman with FGM/C or ever having received FGM/C training. 
Participants scored toward the higher end of the Negative Attitudes scale (mean – 16.4, possible 
range 5-20), while scores on the Empathetic Attitudes fell around the middle range (mean – 
11.24, possible range 5-20). The only statistically significant factor associated with either 
attitudes score was women had significantly less Negative Attitudes toward FGM/C compared 
with men. Participants scored an average of 11.48 (possible range 5-20) on the Confidence for 
Clinical FGM/C Care scale indicating a moderate level of confidence, while they scored an 
average of 9.08 (possible range 3-12) indicating higher Confidence in Critical Communication 
Skills for FGM/C Care scale. Factors associated with higher Confidence for Clinical FGM/C 
Care scores include more awareness of health complications, having ever cared for a woman 
with FGM/C, being a woman, identifying as a person of color, and more than 5 years in clinical 
practice. The only factor associated with increased Confidence in Critical Communication Skills 
for FGM/C Care was higher levels of awareness of health complications for FGM/C.  
 
Conclusion: Health care providers would be well served by comprehensive training for the care 
of women and girls affected by FGM/C. Future trainings should include didactic content that 
address the potential health complications of FGM/C, as well as opportunities to explore their 
attitudes toward FGM/C and those who practice FGM/C and to build confidence in their clinical 
and communications skills to care for this underserved population.  
 
Trial Registration: Clinical Trials.Gov ID # NCT03249649, Study ID# 5252. Public website: 
https://clinicaltrials.gov/ct2/show/NCT03249649 
 
Key Words: Female Genital Cutting, Female Genital Mutilation, Female Circumcision, Health 






Female Genital Mutilation/Cutting (FGM/C) includes procedures that intentionally alter or 
cause harm to female genital organs for non-medical reasons and affects approximately 200 
million women and girls globally.78 FGM/C is practiced in 30 countries with the majority in Sub-
Saharan Africa, and others in the Middle East and South Asia.1,3 Although FGM/C prevalence 
rates are falling globally, the number of girls and women affected will rise in coming decades 
because of persistently high fertility rates in FGM/C practicing countries.1 The COVID 
emergency is currently contributing to a rise in cutting in some regions, with an estimated 
additional 2 million girls at risk for FGM/C.79 In the United States of America (USA), the 
Centers for Disease Control (CDC) estimates that 545,000 women and girls may have undergone 
FGM/C or been born to women from FGM/C-practicing countries.31 This latter group is often 
assumed to be at-risk for FGM/C. Health care providers in countries where FGMC is not 
normative are increasingly likely to care for affected women and girls due to global migration 
trends and must be able to meet the health care needs of this group.1  
FGM/C is conducted on girls between infancy and adolescence, usually by the age of 15, 
and may include practices from a symbolic nicking of the clitoris to infibulation (cutting and 
sewing a narrowed vaginal opening) depending on the region and cultural group.1 FGM/C is 
primarily conducted by non-medical providers, such as traditional birth attendants, although 
there is a trend toward medicalization (when FGM/C is performed by a health care provider).80 
All types of FGM/C have been associated with adverse health consequences including, adverse 
immediate, gynecologic, obstetric, mental and sexual health outcomes; however, not all women 
with FGM/C will experience adverse health effects, and more severe morbidity is associated with 
more extensive forms of cutting.2,14 Women and girls who have experienced FGM/C require 
 52 
specialized health care to address the possible health complications.12–18 For women with Type 3 
FGM/C, defibulation, or the surgical release of the FGM/C scar to widen the vaginal open, is an 
important intervention that can lessen or eliminate some health complications of FGM/C and 
prevent some complications of childbirth associated with FGM/C.81 However, health care 
providers rarely receive training for the care of women and girls who have experienced 
FGM/C,4,6–10 and obstetric providers rarely receive training to perform defibulation.50 In the US 
and other Western countries, health care providers may find themselves facing ethical dilemmas 
as they balance an opposition to FGM/C as a practice with adult women’s right to bodily 
modifications. A recent survey of obstetric providers in the US found that approximately 30% 
would perform reinfibulation, a type of FGM/C that includes the partial or complete re-suturing 
of the vulva following defibulation, if a woman requested it.50 Those providers who have 
received training often report that they would benefit from additional training.7,53,82,83 
WHO defines quality care as being effective, efficient, accessible, patient-centered, 
equitable, and safe.25 Although there are guidelines available for the care of women and girls 
affected by FGM/C from the World Health Organization (WHO), and professional and advocacy 
groups, the health outcomes and experiences of FGM/C affected populations receiving care in 
the diaspora are poor.2,30 Caesarean births rates are elevated for non-obstetric reasons;84,85 
women report fear of and a lack of trust in their health care providers;37,47 women experience 
barriers to care that result in delays;49 they are less likely to access preventative health services;49 
and they experience disrespect and stigma in the health care setting.39 Women and girls may not 
report FGM/C or associated symptoms because of negative attitudes of health care providers, or 
because they may not realize the symptom may be related to their FGM/C status.41,43 The lack of 
health care provider awareness about the health consequences of FGM/C further degrades quality 
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of care.11 In order to provide quality care for FGM/C, health care providers must be aware of the 
potential health complications of FGM/C, be confident in their ability to manage care for women 
and girls who have experienced FGM/C, and understand how their own attitudes toward FGM/C 
and those affected by the practice may impact how they provide care.  
 
Conceptual Approach 
The Knowledge, Attitudes, and Practices (KAP) framework is often used to assess health 
care providers who care for women and girls affected by FGM/C; however, we were not able to 
identify any validated measures for FGM/C.4 The KAP framework theorizes that an individual 
learns about a topic (knowledge), develops some affective response (attitude), and engages in a 
behavior (practice) – often these factors influence one another in multidirectional ways.86 
Existing studies assessing health care providers’ knowledge, attitudes, and practices have 
typically reported their results as purely descriptive, without exploring the relationships between 
knowledge, attitudes and practices or considering health care provider characteristics, such as 
demographics or past experiences with FGM/C, as confounders to these relationships.4,26  
 
Purpose 
The goal of this study is to describe and explore the relationship between provider 
characteristics, awareness of the health complications of FGM/C (knowledge), attitudes toward 
FGM/C, and confidence in the ability to care for patients affected by FGM/C (practice). We 
elected to measure health care provider awareness of health complications because an important 
reason that FGM/C is opposed is because of the harm that it causes in the form of adverse health 
complications. Self-reported confidence is a proxy for practice when we cannot directly observe 
provider care.66 A more rigorous examination of providers’ awareness, attitudes and confidence 
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will provide a clearer direction for the FGM/C related training and education that providers 




We conducted an online cross-sectional survey of health care providers at the time of 
registration in a workshop titled “Optimizing Care for Women and Girls Affected by FGM/C” in 
the greater Phoenix and Tucson, Arizona and Baltimore, Maryland areas. This survey was 
embedded into a larger program funded by the Department of Health and Human Service/ Office 
on Women’s Health (grant number # ASTWH160045-02-00) whose primary aim was to enhance 
culturally-informed health care services for women affected by FGM/C.  
 
Recruitment and Study Population 
Health care providers were invited to participate via an email invitation to a workshop 
and/or grand rounds presentation on FGM/C between September 2016 – May 2017 for Phoenix 
and Tucson, Arizona and in September-October 2018 for the greater Baltimore, Maryland areas. 
Participants were recruited via email to hospital department chairs, residency program directors, 
medical directors, nursing and medical faculty, and professional organizations who then shared 
the email invitations via their list-servs. Emails included a registration link, and an invitation to 
complete the survey. Emails were distributed to list-servs at 14 health care institutions in 
Phoenix and Tucson, Arizona, and broadly distributed within the Johns Hopkins Health System 
and Johns Hopkins University Schools of Medicine, Nursing and Public Health as well as to 
professional organizations in the greater Baltimore, Maryland and Washington D.C. area. Email 
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invitations to the workshop were sent at three time points starting 1-month prior to the respective 
event.  
The Greater Baltimore area is home to large populations of migrants from Sudan, 
Ethiopia and Eritrea, while Arizona has received a large number of Somali refugees.87,88 These 
countries have high FGM/C prevalence (74-98%), and FGM/C type in these countries tends to be 
Type 3 – the most extensive form of cutting with the highest rate of mordibity.1  
 
Measures 
The online questionnaire included four sections: clinician characteristics (demographics, 
scope of clinical practice, and previous clinical experiences related to FGM/C), awareness of 
health complications of FGM/C, attitudes toward FGM/C, and confidence in providing care for 
women with FGM/C. Providers self-report of race and ethnicity was recorded as Black, 
Hispanic/ Latino, Asian, Native American/ Indigenous, or Other Non-White.  
The attitudes and confidence measures were developed and validated by our research 
team – the psychometric validation of the attitudes and confidence scales are presented in a 
separate manuscript. We measured awareness of health complications of FGM/C by asking 
respondents to note which of 33 possible health complications associated with FGM/C they were 
aware of prior to seeing the list. The 33-item checklist, based on the health complications of 
FGM/C identified by the 2016 WHO Guidelines, were sorted into five areas including immediate 
post-FGMC, obstetric, gynecologic, sexual, and psychological.2 The final score of awareness is 
the number of items checked. The Attitudes measure includes two subscales “Negative Attitudes 
toward FGM/C and Those Affected by the Practice” (referred to henceforth as Negative Attitudes 
scale) and “Empathetic Attitudes toward FGM/C and Those Affected by the Practice” (referred 
to henceforth as Empathetic Attitudes scale). The Attitudes measures include items that assess 
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attitudes towards not just FGM/C, but also towards those affected by the practice including 
women who have undergone FGM/C and families and communities that continue to practice 
FGM/C. The Confidence measure also includes two subscales “Confidence in Clinical FGM/C 
Care” and “Confidence in Critical Communication Skills for FGM/C Care.” The attitudes and 
confidence scales both have Likert response options from 1=strongly disagree, 2=disagree, 
3=agree and 4=strongly agree. See table #12 for sample items from each measure and 
Cronbach’s alphas.  
 
Table 12 Attitudes and Confidence Scale Characteristics and Sample Items 
SCALE NAMES AND EXAMPLE ITEMS   
 Cronbach’s Alpha  Number of Items 
Negative Attitudes toward FGM/C and those affected by the practice  0.814 5 
Health Care Providers who perform any form of FGM/C, including 
symbolic nicking, should be charged with a crime 
  
Empathetic Attitudes toward FGM/C and those affected by the practice  0.628 5 
Symbolic nicking or cutting of the female genitalia is an effective way to 
reduce the harm of FGM/C compared to more extensive procedures 
  
Confidence in Clinical FGM/C Care (5 items) 0.857 5 
On inspection of the female genitalia, I can identify a woman with FGM/C   
Confidence in Critical Communication Skills for FGM/C Care  0.694 3 





 We analyzed data using SPSS (version 26) for statistical analysis. This analysis includes 
a combined data set reflecting the locations where we recruited participants (Arizona and 
Maryland). The number of valid and missing responses are noted in the demographic and 
regression tables. We addressed missing data in scale scores using replacement for the average 
for any participants who had completed at least 75% of the items for the 5 item scales, and 66% 
of the items for the 3-items scales. Descriptive statistics are presented as count and percentages. 
We used multivariable linear regression to explore variables associated with attitudes and 
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confidence in order to understand what provider characteristics are associated with different 
levels of confidence, and more or less negative and empathetic attitudes. We used Poisson 
regression to explore variables associated with the number of health complications of FGM/C a 
provider is aware of in order explore provide characteristics associated with more awareness of 
the health complications of FGM/C. We examined participant characteristics (women’s health 
clinical specialty, years of experience dichotomized as <5 years or 5 years or more, gender, and 
race dichotomized as person of color or white) and previous FGM/C experiences (having ever 
cared for a woman who had experienced FGM/C, ever received training for the care for women 
who have experienced FGM/C) as covariates.   
 
Ethics Statement 
We received approval from the Arizona State University Institutional Review Board 
(IRB), and the Johns Hopkins Medical Institute IRB. Participation was voluntary and 
anonymous. No incentives were offered for participating in the study. Electronic consent was 




A total of 796 individuals attended training events in Arizona and 101 in Maryland for a 
total of 897 possible survey participants. A total of 354 participants completed the online survey 
for a response rate of 39.5%, of whom n=164 were physicians or medical residents, nurse-
practitioners or nurse-midwives. The remaining 190 survey participants were medical and 
nursing students, nurses, mental health providers, social workers, and other public health 
workers.  
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Participants for this analysis were predominantly physicians (28%) or resident physicians 
(48.8%), female (73.2%), and white (76.8%). About half the sample specialized in women’s 
health (47%), and the majority had less than 5 year of clinical experience (62.2%). See table #13 
for detailed participant characteristics. 
 




Clinical Practice  
- Outpatient Medical Care  
- Resident 80 (48.8) 
- Physician 46 (28.0) 
- CNM 28 (17.1) 
- NP 10 (6.1) 
Gender  
- Female 120 (73.2) 
- Male 33 (20.1) 
- Missing/ Declined/ Other/ Trans 11 (6.7) 
Race/ Ethnicity  
- Person of Color 37 (22.6) 
- Latino/ Hispanic 11 (6.7) 
- Asian 16 (9.8) 
- Black/ African American/ Native 
American/ Other Non-White* 
10 (6.1) 
- White 126 (76.8) 
- Missing/ Declined 1 (0.6) 
Women’s Health Specialty  
- Yes 77 (47.0) 
- No 79 (48.2) 
- Missing 8 (4.9) 
Scope of Practice includes BIRTH 
(Ob/Gyn, Midwife) 
 
- Yes 76 (46.3) 
- No 80 (48.8) 
- Missing 8 (4.9) 
Years in Practice  
< 5 102 (62.2) 
5-10 22 (13.4) 
10-20 16 (9.8) 
>20 23 (14.0) 
Missing/ Declined 1 (0.6) 
*Due to small n in these groups, they were collapsed to protect participant confidentiality 
 
Most participants had previously cared for a patient with FGM/C (65.9%), though less than half 
had received training in how to care for women affected by FGM/C (41.5%). Just over half were 
aware of the WHO FGM/C type system (55.5%), and two-thirds (64%) were aware of 
defibulation. There were no significant differences in these experiences by site. See table #14.  
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 N (%) 
Ever Cared for Patient with FGM/C  
- Yes 108 (65.9) 
- No 56 (34.1) 
Previous FGM/C Training  
- Yes 68 (41.5) 
- No 96 (58.5) 
Aware of Defibulation?  
- Yes 105 (64.0) 
- No 59 (36.0) 
 
Health Care Provide Awareness, Attitudes and Confidence for FGM/C 
 Participants were asked to indicate which of the FGM/C complications they were aware 
of prior to participating in the study. See Figure #6 for all Health Complications of FGM/C 
Listed and frequencies selected by study participants.  
 60 
Figure 6 Awareness of Health Complications of FGM/C 
 
*n=161, 3 participants did not complete any items for this scale  
 
Health care providers in our sample were aware of most of the 33 FGMC-related complications 
(median=25, IQR 17.5 - 30). Participants were aware of a median of 9 (IQR 7-10) out of ten 
possible immediate complications. Nearly all (91.9%) were aware that FGM/C can cause pain, 
while about two-thirds were aware that FGM/C can result in shock (64.6%) or death (66.5%). 
Respondents were aware of a median of 6 (IQR 3-8.5) out of ten possible obstetric 
complications. The largest proportion of participants were aware that FGM/C is associated with 
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increased use of episiotomy (71.4%), while the smallest were aware that FGM/C was associated 
with increased rates of neonates who require resuscitation at delivery (28.0%). Participants were 
aware of an average of 3.71 (SD 1.73) of 5 possible sexual complications with most aware that 
FGM/C is associated with pain with sex (83.2%) and the fewest aware that FGM/C is associated 
with decreased lubrication during intercourse (57.1%). Participants were aware of a median of 3 
(IQR 3-3) of 3 possible mental health complications with approximately 80% aware that FGM/C 
is associated with increased rates of depression, anxiety and PTSD. Participants were aware of a 
median of 4 (IQR 2-5) of 5 longer term gynecologic complications with most participants aware 
that FGM/C is associated with chronic vulvar and clitoral pain (86.3%), and the fewest aware 
that FGM/C is associated with dysmenorrhea (47.2%).  
 Participants scored an average of 16.21 on the Negative Attitudes scale indicating that 
participants tended to agree or strongly agree with statements endorsing more negative attitudes 
toward FGM/C, those who are affected, and those who practice it. The minimum score reported 
was 10 out of a possible 20, which means that no participants strongly disagreed with all 
statements. Participants scored an average of 11.28 on the Empathetic Attitudes scale which 
represents the middle range of possible scores and may suggest ambivalence toward the 
statements endorsing empathetic attitudes. There were few participants whose scores fell at the 
extremes of the scale. Participants scored an average of 11.38 on the Confidence for Clinical 
FGM/C Care scale indicating a moderate level of confidence in participant abilities to provide 
appropriate clinical care for women affected by FGM/C. Participants scored an average of 9.02 
on the Confidence in Critical Communication Skills for FGM/C Care scale. Participants tended 
to have a higher level of confidence in their communication skills for women affected by FGM/C 
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compared to their clinical skills. See table #15 for descriptive statistics for the attitudes and 
confidence subscales. 
 
Table 15 Attitudes and Confidence Scales - Descriptive Statistics 
 
 n Mean  Std. 
Dev. 
Min Max Possible 
Range 
Health Care Provider Attitudes Toward FGM/C and those who 
practice FGM/C 
 
Negative attitudes toward FGM/C and those who practice  154 16.21 2.40 10 20 5-20 
Empathetic attitudes towards FGM/C and those who practice 150 11.28 2.33 5 20 5-20 
Health Care Provider Confidence for the Care of Women 
Affected by FGM/C 
 
Confidence for Clinical FGM/C Care 155 11.38 2.98 5 20 5-20 
Confidence in Critical Communication Skills for FGM/C Care 157 9.02 1.44 3 12 3-12 
 
Relationship between Awareness, Attitudes and Confidence  
 We explored factors associated with more awareness of health complications of FGM/C 
using multivariable analysis. All covariables were included in each model. Participants who had 
ever cared for a woman affected by FGM/C or ever received training for the care of women 
affected by FGM/C were aware of significantly more health complications of FGM/C than those 
without those experiences. Clinical practice in women’s health, female gender, identifying as a 
person of color and years’ experience were not associated with significantly increased awareness 
of health complications. See table #16.  
 
Table 16 Factors Associated with Awareness of Health Complications of FGM/C – Multivariable Analysis 
(n=144)* 
 B 95% CI p-value 
Women’s Health Focused Clinician 0.042 -0.040 – 0.125 0.314 
Ever Care for a Woman Affected by FGM/C 0.162 0.069 – 0.255 0.001* 
Ever Received Training for Care of Women Affected by FGM/C 0.093 0.020 – 0.167 0.013* 
Female Gender 0.037 -0.057 – 0.131 0.437 
Person of Color 0.000 -0.084 - 0.083  0.992 
More than 5 years Clinical Experience -0.028 -0.101 – 0.045 0.450 
*Participants who were missing one of more of the predictor variables were excluded from the analysis 
 
We explored factors associated with increased health care provider confidence for the care of 
women affected by FGM/C. Factors associated with increased health care provider scores on the 
Confidence for Clinical FGM/C Care include being aware of more health complications of 
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FGM/C, having ever cared for a woman affected by FGM/C, identifying as female, identifying 
as a person of color, and having more than 5 years clinical experience. Neither having received 
previous training for FGM/C nor being a women’s health care provider were significantly 
associated with higher scores for Confidence for Clinical FGM/C Care. The only factor 
significantly associated with higher scores on the Confidence in Critical Communication Skills 
scores was awareness of more health complications of FGM/C.  
 
Table 17 Factors Associated with Health Care Provider Confidence  – Multivariable Analysis 
 
 Confidence for Clinical FGM/C Care 
(n=139)* 
Confidence in Critical 
Communication Skills for FGM/C 
(n=140)* 
 B (S) 95% CI p-value B (S) 95% CI p-value 
Awareness of Health 
Complications 
0.265 0.047 – 0.140 <0.001 0.187 0.002 – 0.059 0.035 
Women’s Health Provider 0.089 -0.365 – 1.389 0.249 0.074 -0.333 – 0.733 0.459 
Ever Care for a Woman 
Affected by FGM/C 
0.340 1.145 – 3.103 <0.001 0.142 -0.181 – 1.002 0.172 
Ever Received Training for 
Care of Women Affected by 
FGM/C 
0.066 -0.408 – 1.182 0.338 -0.012 -0.515 – 0.450 0.894 
Female Gender 0.178 0.320 – 2.265 0.010 -0.110 -0.625 – 0.559 0.755 
Person of Color 0.161 0.242 – 2.029 0.013 0.026 -0.459 – 0.631 0.755 
More than 5 years Clinical 
Experience 
0.135 0.037 – 1.607 0.040 0.034 -0.383 – 0.571 0.696 
*Participants who were missing one of more of the predictor variables were excluded from the analysis 
 
Next we explored participant characteristics associated with attitudes toward FGM/C and those 
affected by the practice.  Women had significantly lower scores on the Negative Attitudes scale 
compared with men. No other factors were significantly associated with negative attitudes 
scores. We did note that those who had ever received training for FGM/C care and those who 
identify as a person of color tended to have lower scores on the negative attitudes scale than their 
counterparts; however, none of these were significant. Only one factor (more than 5 years 
clinical experience) had a significant associated with scores on the Empathetic Attitudes scale. 
Participants with more than 5 years of clinical experience has significantly less empathetic 
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attitudes towards FGM/C compared with participants who had less than 5 years clinical 
experience. See table #18 for detailed results of the multivariable regression. 
 
Table 18 Factors Associated with Health Care Provider Attitudes – Multivariable Analysis 
 
 Negative Attitudes (n=138)* Empathetic Attitudes N=134)* 
 B 95% CI p-value B 95% CI p-value 
Awareness of Health Complications 0.037 -0.039 – 0.060 0.674 0.067 -0.031 – 0.070 0.452 
Women’s Health Focused Clinician 0.033 -0.790 – 1.093 0.751 0.051 -0.734 – 1.219  0.624 
Ever Care for a Woman Affected by 
FGM/C 
0.084 -0.618 – 1.445 0.429 0.088 -0.618 – 1.510  0.409 
Ever Received Training for Care of Women 
Affected by FGM/C 
-0.160 -1.589 – 0.092 0.080 0.119 -0.310 – 1.455  0.201 
Female Gender -0.234 -2.380 – -0.332 0.010* 0.060 -0.727 – 1.448 0.513 
Person of Color -0.109 -1.586 – 0.337 0.201 0.067 -0.598 – 1.376  0.437 
More than 5 years Clinical Experience 0.036 -0.654 – 1.005 0677 -0.180 -1.776 – -0.039 0.041 
*Participants who were missing one of more of the predictor variables were excluded from the analysis 
 
 Defibulation/ Reinfibulation 
 We performed descriptive analyses of items related to defibulation and reinfibulation 
among health care providers who attend births including obstetrician/ gynecologists, obstetrician/ 
gynecologist residents, and nurse-midwives (n=76). Only 8 (10.5%) providers responded that 
they had been trained to perform defibulation. Almost half of those who attend births (42.1%) 
agreed or strongly agreed that heath care providers should perform reinfibulation if the woman 
requests it. Health care providers attending births were also asked to rate their confidence related 
to defibulation and reinfibulation. See figure #7. 
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About a third of health care providers who attend births agreed or strongly agreed that they can 
perform defibulation during the second stage of labor (35.3%). About a quarter agree or strongly 
agree that they can defibulate an FGM/C-related vulvar scar (26.4%). This difference may reflect 
a difference in scope of practice because midwives are less likely to perform antenatal 
defibulation, which is usually performed in an operating room. Fewer than half of respondents 
(45.9%) agreed or strongly agreed that they could respond to a request for reinfibulation with 
cultural humility illustrating that discussions around reinfibulation remain challenging for most 
health care providers.  
Discussion 
This study provides the first exploration of the relationship between health care provider 
characteristics, awareness of health complications, attitudes toward FGM/C, and confidence for 
FGM/C care using psychometrically validated scales. Existing studies assessing health care 
providers caring for women and girls affected by FGM/C tend to report descriptive findings, 
without exploring how these factors are interrelated. Our study sample includes a diverse cross-
section of health care providers including physicians, nurse-practitioners, and nurse-midwives 
who practice in regions with considerable numbers of refugees and immigrants from regions 
0 20 40 60 80 100 120
Perform defibulation of an FGC-related vulvar scar (n=72)
Perform defibulation during the second stage of labor (n=73)
Respond to a requests for reinfibulation (re-closing of the
vulvar scar following childbirth) with cultural humility (n=72)
Confidence for Defibulation/ Reinfibulation
Strongly Disagree Disagree Agree Strongly Agree
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where FGM/C is common. Of the providers we surveyed, two-thirds had ever cared for a patient 
with FGM/C but fewer than half had received any training for the care of those affected by 
FGM/C. This is consistent with a recent US survey of obstetric providers which found that 56% 
has received some didactic and 26% hands-on clinical training, and 60% had ever cared for 
someone with FGM/C.50 
In developing our study, we elected to use awareness of health complications related to 
FGM/C as our ‘knowledge’ measure. The negative health effects of FGM/C are one of the 
primary reasons for calls to eliminate the practice. FGM/C is considered a violation of human 
rights and rights of the child because it causes harm, both immediate trauma and long-terms 
health effects.89 Awareness of health complications is important because health care providers 
must be aware in order to adequately assess and treat these complications. For example, if a 
provider is unaware that FGM/C Type 3 is associated with recurrent UTIs, the provider may 
repeatedly prescribed antibiotics instead of releasing the scar as indicated. 30 The health care 
providers in our sample were on average aware of two-thirds of the complications associated 
with FGM/C according to the WHO index of complications. There are important limitations 
when considering the list of FGM/C associated complications as published by WHO. Many of 
the studies documenting these health complications had limited or poor-quality data 
characterized by small sample sizes, the lack of control groups, and analysis absent assessment 
for confounding factors. A recent study found that for Somali refugee women, exposure to 
victimization and having experienced FGM/C were each associated with increased rates of health 
complications.88 Further, some of the complications associated with FGM/C are the result of 
iatrogenic mismanagement, rather than direct results of the health complications – such as the 
excess use of cesarean to avoid managing the vulvar scar from Type 3 FGM/C.42 Given the 
 67 
recent publication of the WHO Clinical Handbook for FGM/C care, a validated measure of 
health care provider knowledge should be developed to strengthen future assessments. 
Awareness of health complications should be an important component of any future validated 
measure.   
 We developed and validated a novel measure of health care provider confidence for this 
study (psychometric validation presented in a separate paper). The measure includes subscales 
for Confidence for Clinical FGM/C Care and Confidence for Critical Communications Skills for 
FGM/C Care. Participants reported moderate levels of confidence for the clinical care of patients 
living with FGM/C with mean scores slightly lower than the median possible score. This is 
consistent with the findings of an existing qualitative synthesis that found health care provider 
are often unsure of what constitutes appropriate care for those affected by FGM/C, and many 
desire additional training.90 Interestingly, having received prior training for FGM/C was not 
significantly associated with increased Confidence for Clinical FGM/C Care. This may indicate 
that existing trainings are inadequate, and do not provide the opportunity for health care 
providers to achieve some competence prior to caring for patients. Simulation based training may 
be an effective modality for FGM/C related care because it has been demonstrated to improve 
health care provider confidence and positively affect patient-outcomes, particularly for care of a 
relatively uncommon condition like FGM/C.91 
Participants in our study reported higher levels of confidence in their communication 
skills with mean scores falling at the higher end of the range possible. This is a more surprising 
finding given existing studies with providers that note their frustration with cross cultural 
communication and lack of confidence with interpreter use.32 Given the research with FGM/C 
affected patients that demonstrates they often feel disrespected and stigmatized by their 
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providers,37 provider confidence may be misplaced. The only factor associated with increased 
confidence in communication was awareness of more complications associated with FGM/C, 
suggesting that the first step toward increasing provider confidence is increasing their knowledge 
and awareness of the condition. Future research should explore how patients and providers 
interpret and experience communication during clinical visits to identify areas of incongruence. 
Research studying patient-provider communication, particularly in the presence of racial, cultural 
and/ or linguistic discordance, has demonstrated that health care providers often experience 
implicit bias that is transmitted to the patient through their communication behaviors.62,92 Health 
care providers caring for women who have experienced FGM/C in the diasporic setting may be 
further influenced by “othering” of African bodies, and moral superiority of opposition to 
FGM/C that may lead to a paternalistic and stigmatizing treatment of women living with 
FGM/C.24 
 Our findings were limited in terms of factors associated with the Negative and 
Empathetic Attitudes subscales. Only one factor had a significant association – identifying as a 
woman was significantly associated with less negative attitudes towards FGM/C compared with 
identifying as a man. Women also had significantly higher scores on the Confidence for Clinical 
FGM/C Care scale. A study conducted in Spain also found significant gender differences; 
women were more likely to detect FGM/C cases and correctly identify FGM/C while men were 
more likely to include reporting women with FGM/C to the authorities as part of their response.53 
No other variables under investigation were significantly associated with scores on the attitudes 
subscales. These scales were developed for use in this study, and likely require further 
refinement including potentially the inclusion of additional items to broaden the range of 
attitudes assessed. Further, our sample was self-selected and so may have less variance in terms 
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of the attitudes compared with a random sample of health care providers. Finally, future research 
should consider investigating the association between health care provider attitudes scores and 
factors such as scores on a validated measure of implicit bias, and/or political affiliation which 
may inform attitudes toward immigrants in our current highly politicized anti-immigrant 
environment.93  
 The attitudes scales that we developed were designed to be used with any health care 
provider, regardless of scope of practice, while the confidence scales were designed for any 
health care provider who provides outpatient care. Women with FGM/C require specialized 
consideration from all health care providers; however, there are important skills for providers 
who attend birth. It is concerning that only about 10% of providers who attend births have been 
trained to perform defibulation, an important intervention for reducing obstetric morbidity.81 
Despite only 10% reporting receiving training for defibulation, about a third agreed or strongly 
agreed that they are confident that they could perform defibulation during the second stage of 
labor. This may represent an over-confidence on the part of providers. We found that almost half 
of providers who attend births agree or strongly agreed that a provider should perform 
reinfibulation if the woman requests it. This is a controversial stance given that reinfibulation is 
considered a form of FGM/C, and thus vehemently opposed by the WHO. This is not completely 
surprising given that no professional health organization has published FGM/C-specific 
guidelines in more than a decade. Reinfibulation is associated with similar health complications 
as other forms of FGM/C. However, there is a dearth of research on the consequences of partial 
defibulation and partial reinfibulation, which may have different outcomes related to possible 
physical health complications or mental health and well-being, particularly genital self-image or 
bodily satisfaction.24 An important difference is that reinfibulation is typically performed on an 
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adult woman who can legally consent to the procedure. In many high-income countries in the 
West, medical ethicists agree that adults have the right to bodily modifications that are without 
direct medical benefits including cosmetic genital surgery.94,95 While the ethics of this debate are 
beyond the scope of this paper, it is important that health care providers receive adequate training 
regarding the ethical dilemmas they may face during the provision of care so that they are not 
surprised by a request, and that they may have a considerate and respectful response should a 
request arise.  
Conclusion 
Few health care providers receive any training for the care of women and girls who have 
experienced FGM/C, and those who have received some training are not necessarily more 
confident in their ability to provide appropriate clinical care for FGM/C. The overall negative 
attitudes toward FGMC and those affected by the practice may be consistent with overall 
discriminatory attitudes toward patients of color in the US. Given the gross disparities in 
maternal and neonatal outcomes by race, strategies to help providers recognize and mitigate their 
negative attitudes are imperative. The high level of willingness to perform reinfibulation paired 
with a lack of understanding and training on how to perform defibulation or manage a vulvar 
scar highlights the need for more explicit guidelines for U.S. providers. Guidelines should 
include a structure for providers to explore their attitudes regarding reinfibulation, obtain 
appropriate training for defibulation and reinfibulation, and guide providers in how to have a 
culturally informed discussion with patients about the health and ethical issues related to a 
woman’s choice.  
Our research has demonstrated innovative and important opportunities for the development 
of future education and training for health care providers caring for women and girls affected by 
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FGM/C. Specifically, future trainings for health care providers should include opportunities to 
practice clinical and communication skills through structured clinical simulations, which are 
more effective than didactic teaching for building health care provider confidence. Trainings 
should also include opportunities for discussion and reflection of individual attitudes toward the 
practice of FGM/C and those who are affected by the practice. Further research should explore 
how simulations and structured discussions around the power dynamics of providing care to 
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Background: Female genital mutilation or cutting (FGM/C) is a cultural practice associated with 
numerous adverse health complications affecting more than 200 million women and girls 
globally and an additional 3 million are at risk each year. Women and girls living with FGM/C 
often do not receive high quality health care services. Qualitative research has demonstrated that 
health care provider attitudes are a critical nexus between knowledge and practice that may 
impact quality of care. The aim of this study was to explore what global clinical and research 
experts considered to be critical areas of knowledge and practice required for quality care, and 
how health provider attitudes may impact the delivery of quality care for those living with 
FGM/C. 
 
Methods: We conducted 31 semi-structured individual interviews with global clinical and 
research experts for FGM/C from 30 countries including participants from Africa, Australia/ 
New Zealand, Europe, the Middle East, and North America. Interview questions explored areas 
of knowledge, attitudes, and practices that participants believe influence quality of care for those 
affected by FGM/C. We used the Framework Method of qualitative data analysis to organize 
themes that emerged, and to explore how they interact to influence quality of care.  
 
Results: Participants identified six areas of knowledge, six of practice, and seven of attitudes 
that contribute to quality care for FGM/C. Areas of knowledge include: general knowledge about 
FGM/C, risk factor, support for FGM/C; unaltered female genital anatomy/ physiology; health 
complications; management of health complications; ethical and legal considerations; and 
patient-provider communication. Areas of practice include: clinical procedures and protocols; 
management of complications; defibulation; other surgical procedures for FGM/C; pediatric 
care; and patient-centered care. Areas of attitudes include attitudes toward: benefits of FGM/C; 
harms of FGM/C; ethical issues; providing care for FGM/C-affected clients; women and girls 
who have experienced FGM/C; communities that practice FGM/C; and affective response to 
FGM/C. We present findings that describe how the interaction between knowledge, attitudes and 
practices influence quality of care.  
 
Conclusions: Global clinical and research experts in FGM/C discussed comprehensive areas of 
knowledge, attitudes, and practices that comprise high quality care for women and girls who 
have experienced FGM/C. These should be integrated into future training curricula for health 
care providers and can be used to develop evaluation metrics. Trainings should support health 
care providers to increase their knowledge, and improve their clinical practice, and require that 
health care providers engage in self-reflection regarding their own attitudes and affective 
response toward FGM/C and affected patients.  
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Scope of the Problem of FGM/C 
Female genital mutilation/ cutting (FGM/C) is a persistent public health problem with 
approximately 200 million women and girls already cut worldwide, with another 3 million at risk 
each year.1 FGM/C is a cultural practice performed on girls from infancy to adolescence, 
depending on the setting, and involves partial or total removal of external female genitalia.1 This 
practice is concentrated in 30 countries throughout the Middle East, Africa and Asia; however, 
due to migration, affected women and girls live around the world.1 Although prevalence rates are 
falling in many countries, population growth data suggest that the total number of affected 
women and girls will continue to rise for several decades.2  This growing population requires 
specialized care because FGM/C is associated with acute and chronic health complications 
negatively affecting genitourinary, obstetric, gynecologic, sexual, and emotional health.3 These 
complications are associated with a yearly estimated cost of 1.4 billion.4 Given the health and 
economic costs, there is an urgency to understand what constitutes quality care for women and 
girls living with FGM/C. 
Care for Women and Girls Affected by FGM/C 
Concurrent with the conceptualization (2016) and data collection for this study (2017-
2018), the WHO published two seminal documents about this topic: the Guidelines on the 
Management of Health Complications of FGM (2016) and the Care of Women and Girls Living 
with FGM: Clinical Handbook (2018).5,6 The WHO Clinical Handbook provides a 
comprehensive overview of clinical care for FGM/C based on existing evidence and expert 
consultation, establishing a new standard for quality care for FGM/C. The WHO states that 
quality health care is safe, effective, timely, efficient, equitable, and person-centered.7 The WHO 
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Clinical Handbook addresses three broad areas:  understanding FGM/C, recommended patient-
provider communication strategies for FGM/C-related health concerns, and recommended 
clinical care strategies to manage specific types FGM/C-related health concerns that women and 
girls may experience (Figure 8).  
Figure 8 WHO Clinical Handbook – Overview of Contents 
 
The Clinical Care for FGM/C chapters include: identifying complications and their etiology, 
history taking, performing a physical exam or mental health assessment, managing 
complications, and referring clients for further management. In addition to the WHO 
publications, professional organizations in Australia, Canada and the United Kingdom have also 
published brief clinical guidelines that address areas such as: understanding the practice of 
FGM/C, ethical and legal considerations, complications associated with FGM, clinical 
management of FGM, child protection, communication with patients, and culturally competent 
care; however, emphasis and level of detail vary considerably.3,5,6,8–10 The WHO Clinical 
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Handbook represents an important advancement toward the establishment of an evidence-based 
guideline to establish what constitutes quality of care for women and girls living with FGM/C.  
 
Quality of Care for Women and Girls Living with FGM/C  
Despite the prevalence of FGM/C and its health burden, most health care providers have 
limited or no training related to FGM/C, making it difficult to provide quality care.11,12,21–24,13–20 
Providers demonstrate knowledge deficits and lack confidence in their ability to provide quality 
care for clients affected by FGM/C.16,23,25,26 Providers report they do not know what constitutes 
quality care for clients living with FGM/C.23,27 This lack of knowledge and clinical practice 
expertise has two important consequences. First, providers risk failing to address the adverse 
effects of FGM/C, potentially causing iatrogenic injury.15,28 For example, a woman with Type 3 
infibulation may present with recurrent genital and urinary tract infections. If the health care 
provider is not aware of the recommended technique of defibulation, an anterior incision to 
release the vulvar scar, or assume that the patient would decline defibulation, the client may not 
be offered this procedure that would likely improve her symptoms and quality of life.29  
Providers who lack knowledge about FGM/C and confidence in FGM/C-related procedures may 
not provide evidence based care in an effort to avoid addressing the FGM/C.30 For example, a 
woman with Type 3 infibulation who is in labor will likely requires defibulation. If a provider is 
unaware of or unskilled in the practice of defibulation, they may instead perform an episiotomy 
or an unnecessary caesarean birth, subjecting women to unnecessary risks associated with 
unindicated surgical procedures.31 Ultimately, a provider’s lack of knowledge and confidence, 
inappropriate practice, and imposition of their own cultural norms and values into the patient-
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provider interaction may be noted by the woman and her community, and result in distrust of the 
health care provider and health system.32 
Health care provider attitudes toward FGM/C may further impact the quality of care by 
influencing the relationship between health care provider knowledge about FGM/C (including its 
harms and recommend treatments) and their clinical practice.32 In countries or communities 
where FGM/C is a normative among some ethnic groups, a provider’s support or opposition to 
FGM/C may be informed by their knowledge of its health complications, cultural beliefs about 
its benefits and importance, and revenue from performing FGM/C.33–35 The religious importance 
of FGM/C in some communities may overshadow existing knowledge about its possible health 
complications.36 Health care providers who support FGM/C may engage in medicalization 
(FGM/C practiced by any category of health care provider in clinical or non-clinical settings) as 
part of their clinical practice for economic benefit33 or because they believe that FGM/C is a 
valuable hygienic or cosmetic procedure.37 Health care providers who oppose FGM/C in 
communities where it is normative may face loss of income and social censure from family or 
community members, thus engendering a conflict between their attitudes toward FGM/C and 
their clinical practice.33 Regardless of region, providers who oppose FGM/C may display shock, 
disgust, or pity when providing clinical care for women and girls living with FGM/C.32 Women 
and girls who experience these affective responses report feelings of shame, stigma, and poor 
body self-image.32 As a consequence, they may delay or avoid care for FGM/C.38,39  
Researchers seeking to assess health care providers caring for those living with FGM/C 
commonly use the Knowledge, Attitudes and Practices framework which fundamentally seek to 
understand the relationship between knowledge and behavior.40,41 The KAP framework theorizes 
that a subject will learn about a topic (knowledge), experience some affective response or feeling 
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(attitude), and then engage in a behavior (practice). The relationships between knowledge, 
attitudes and practice may vary considerably and are not necessarily linear. Several recent 
systematic reviews of studies assessing the knowledge, attitudes, and practices (KAP) of health 
care providers42,43 and their experiences providing care16,21,  providers are often not adequately 
prepared to provide quality care for those living with FGM/C. A recent systematic review of 
health care provider KAP surveys found  considerable variability in terms of what types of items 
are included within existing surveys highlighting that, until recently, researchers have lacked a 
framework to define what constitutes quality care for women and girls living with FGM/C.44  
While the publication of the WHO Clinical Handbook represents an important 
advancement in the establishment of what constitutes quality care for women and girls living 
with FGM/C, it is limited in the extent to which it addresses the effect of attitudes on knowledge 
acquisition and clinical practice. The aim of this study was to explore the knowledge, attitudes, 
and practices that are important to ensuring quality care for women and girls living with FGM/C, 
and how these factors interact to affect quality of care. Given the concurrent publication of new 
comprehensive guidelines for FGM/C from the World Health Organization, we organized our 
findings to confirm and expand upon what is included in these publications. We further explored 
the ways in which health care provider attitudes may provide insights and opportunities for the 
further advancement of quality care for women and girls living with FGM/C. The results of this 
study may be used to inform the creation of health care provider trainings on this topic and to 
inform the construction of measures to better assess health care provider knowledge, attitudes, 






 We conducted a cross-sectional qualitative study utilizing in-depth individual interviews.   
 
Recruitment and Consent 
We began recruitment by creating a purposive sampling strategy of clinical and research 
experts in FGM/C stratified by clinical practice area and/or research expertise, and region (high 
prevalence versus diaspora). We defined “high prevalence” as those countries identified by 
UNICEF/ WHO where FGM/C has been practiced traditionally among some communities, and 
‘diaspora’ as countries where FGM/C is not normative but home to a significant number of 
immigrants or refugees from high prevalence countries. We created a preliminary list of potential 
participants in consultation with the WHO Office of Reproductive Health and Research.  
Inclusion criteria included clinical or research expertise in FGM/C as demonstrated by clinical 
practice and/or publication and research history, possession of a clinical or research degree, and 
the ability to conduct the interview in English or French. We contacted potential participants via 
email. Those willing and eligible to enroll were scheduled for an interview via their preferred 
modality. We sent follow-up emails to past participants requesting referrals for the strata where 
we had not yet enrolled enough participants.  
 
Setting and Participants 
According to participant preference, we conducted interviews in-person, via telephone, or 
through secure internet-based voice calls. Interviews were conducted between September 2018 
and January 2019 by author CM, a nurse-midwife experienced in FGM/C care and trained in 
qualitative research. Interviews were conducted in English or French (via interpreter). Four 
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interviews were conducted in-person, and twenty-five by phone or secure HIPAA-compliant 
voice-over-internet-protocol (VOIP). Participants selected their own location from which to 
receive the interview call or conduct the in-person interview. The interviewer began by 
explaining the study’s purpose and procedures and obtaining verbal informed consent. 
Interviews, which were audio-recorded with participants’ permission, lasted from 45–150 
minutes. Two participants provided written responses due to poor audio connection. 
 
Qualitative Interview Guide 
The semi-structured interview guide was developed by the lead author in collaboration 
with three other study team members with expertise in FGM/C, including a nurse-midwife, a 
physician specializing in obstetrics/gynecology, and a public health researcher. The guide was 
informed by a recent review of existing measures of knowledge, attitudes and practices.44 The 
guide was written in consultation with researchers and clinicians with FGM/C expertise, and 
staff who focus on FGM/C from the WHO Office of Reproductive Health and Research. These 
collaborators provided written comments that were integrated into the interview guide. The guide 
explored the participant’s opinion of: 1) the knowledge required to provide quality care for 
women and girls affected by FGM/C; 2) the clinical practices necessary for the provision of 
high-quality health care for women and girls affected by FGM/C; and 3) the attitudes that health 
care providers may hold related to FGM/C and the care of FGM/C-affected women and girls.  
 
Analysis 
Audio recordings were immediately transferred from the recording device to a secure 
server hosted by Johns Hopkins University and erased from the recording device. Audio 
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recordings were transcribed verbatim and error checked by a certified transcription and 
translation company. Written comments submitted in French (n=2) were translated into English 
for analysis. 
We used NVivo 12 software for the analysis of qualitative data. We used the Framework 
method to integrate the qualitative data from experts with existing literature in order to confirm, 
revise, and expand upon what has been previously measured.45 The Framework method analysis 
is an appropriate and robust method for qualitative data analysis because it enables the researcher 
to expand on existing knowledge and consider how existing frameworks support (or limit) the 
state of science. The method is particularly well-suited for data sets that cover a discrete and 
common set of topics, including the discrete categories of knowledge, attitudes, and practices for 
the care of women and girls affected by FGM. This method is useful for multi-disciplinary health 
research because it helps compare and contrast findings across groups (such as high prevalence 
and diaspora participants).  
The Framework Method comprises discrete steps which we applied systematically.45 Co-
authors CM and NW led the qualitative analysis, and began by developing a preliminary 
codebook based on the a priori framework compromised of existing knowledge, attitudes, and 
practices domains published in a recent systematic review assessing the content of existing KAP 
measures.44 Then, CM and NW each independently coded the same four interviews using the 
preliminary codebook and adding additional codes as they emerged, organizing them into the 
expanding codebook. CM and NW then discussed the initial independent coding, identifying 
differences in interpretations of existing codes, and possible additional codes. After coming to 
consensus on the revised codebook, NW and CM jointly wrote a brief summary of each code, 
capturing their main ideas to ensure consistent code application. Next, CM and NW coded the 
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remaining transcripts. CM and NW then compared codes again and discussed discrepancies to 
achieve consensus. CM and NW reviewed the source data for each code to ensure all levels of 
abstraction were interpretable and consistent with the included codes. CM and NW then 
reviewed the complete codebook and further sorted individual codes into subdomains within the 
knowledge, attitudes and practices domains respectively. See figure #9 for an overview of the 
coding process. 
Figure 9 Framework Method - Process Overview 
 
 
We labeled codes as being consistent with the WHO Clinical Handbook, as not being 
included in the handbook, or as having a substantially different emphasis than the ones included 
in the handbook. As we developed our final framework for Knowledge, Attitudes, and Practices 
we noted the areas that represent convergence with the WHO Clinical Handbook, general 
consensus within the participants interviews, and themes that diverged from both the WHO 
Clinical Handbook and other participants. Once we completed our framework analysis and 
sorting all themes into subdomains within Knowledge, Attitudes, and Practices, we then explored 
the codes within the attitude subdomains labelling those that addressed the intersection of 
attitudes with knowledge and/or practices that participants expressed may impact the quality of 
care. Because our aim is to create a comprehensive framework of knowledge, attitudes, and 
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practices to inform global guidance on FGM/C care and the development of a standardized KAP 
measure, we focus our presentation of results on areas there was consensus among participants.   
 
Ethics Statement  
The Institutional Review Boards of Johns Hopkins Medicine and the WHO granted 
research and ethical approval for the conduct of this study.  
 
Results 
We conducted a total of 31 in-depth interviews with 15 participants from high prevalence 
countries and 17 participants from diaspora countries. Table #19 describes the sample by region 
and profession.  
Table 19 Qualitative Interview Participants – Region and Profession 
 
 Reproductive  
Health Providers 
Primary Care/  
Pediatric 
Nursing Researchers TOTAL 
High Prevalence 4 4 3 3 14 
Diaspora  6 3 3 5 17 
TOTAL 10 6 6 8 31 
 
Table #20 describes the participant characteristics. The participants were mostly female 
(77%). Nearly half of participants held a PhD (48%), while the remainder held a clinical or 
Master’s degree. The most common religious affiliations were Muslim (10%), None (30%) and 
Christian (27%). There was a wide range of ages (31-77 years old), and years conducting clinical 
or research work related to FGM/C (6-55 years).  
Table 20 Participant Characteristics 
(n=31) 
Characteristic N (%) 
Region of Origin 





























 Range Mean Standard 
Deviation 
Age 31-77 51.8 11.3 
Years in Profession 5-55 20.8 10.85 
Years in FGMC** 6-55 21.4 13.6 
*One participant reported MD/ PhD 
**3 missing values 
 
The qualitative analysis via the Framework method resulted in six subdomains of 
knowledge and practices, respectively, and seven subdomains of attitudes. We have bolded those 
themes that were either not included in, or emphasis diverged significantly from, the WHO 
Clinical Handbook. See Figures #10, 11, and 12. Our analysis of the relationship between the 
subdomains further revealed that health care provider attitudes are constantly interacting with 
knowledge, and practices to inform the quality of care provided. We found that attitudes towards 
FGM/C, the women who have experienced it, families and communities that perpetuate the 
practice, and the ethical issues that arise during care can all influence a provider’s knowledge 
and inform their clinical practices. 
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Figure 10 Knowledge Subdomains and Themes 
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Attitudes Towards FGM/C – Interactions with Knowledge and Practices  
Consistent with the WHO Clinical Handbook, participants stated that health care providers 
must have a general understanding of FGM/C including being knowledgeable about the types of 
FGM/C (including that medicalization and reinfibulation are forms of FGM/C), who is at risk for 
FGM/C, and the reasons that some people support FGM/C. Beyond the WHO Clinical 
Handbook, participants stressed that it is important for health care providers to understand the 
social and cultural significance of FGM/C, including consequences of undergoing or not 
undergoing FGM/C. This knowledge informs clinical practice by influencing provider behavior 
for screening and assessment of FGM/C, aids the providers ability to identify FGM/C and 
document FGM/C cases, and refines their skill for performing appropriate genital exams for 
those with FGM/C. Participants reflected on the importance of asking the patient to tell her 
FGM/C story so that the provider can understand what the practice means to her. Consistent with 
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female sexual response including the role of factors such as arousal, desire, and relationship 
characteristics. Participants further stressed that comprehensive knowledge about unaltered 
female genital anatomy and physiology is extremely important for all health care providers, 
including traditional birth attendants. 
 
“. . . some categories of midwives . . . [do] not know definitely the physiology and anatomy of 
these genital parts so they need to concentrate in raising their knowledge about this . . .” 
(Female, Midwife, High Prevalence/ Sudan) 
 
This knowledge enables health care providers to identify structures affected by cutting, what 
symptoms a woman might experience based on what was cut, and determine what treatments 
might be effective to relieve symptoms.  
Participants noted that health care provider attitudes regarding the benefits or harms of 
FGM/C, their affective responses to patients with FGM/C, and their attitude toward providing 
FGM/C- related care may affect quality of care particularly its effectiveness and patient-
centeredness. While the benefits and harms of FGM/C discussed by participants were consistent 
with the WHO Clinical Handbook, WHO focused on how to respond to patients who endorse 
benefits of FGM/C, while participants focused on health care provider attitudes. Participants 
acknowledged that health care providers from communities that practice FGM/C may share 
beliefs about the benefits of FGM/C, disbelieve or downplay its possible harms, or believe that 
the benefits of FGM/C outweigh the health risks. Participants discussed how health care provider 
attitudes toward the benefits of FGM/C may influence how receptive they are to learning about 
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the harms of FGM/C, participation in medicalization of FGM/C, performance of reinfibulation, 
and counseling families against the practice.  
 
A healthcare provider coming from such communities . . . [probably supports] the 
traditional practice because of their socialization about FGM . . . if [they don’t] feel like 
FGM is a big thing or, an infringement of human rights, or don't feel like it has a lot of 
health consequences, then they might easily overlook the kinds of problems that a woman 
has presented. (Female, Clinical Officer, High Prevalence/ Kenya) 
 
Participants from high prevalence countries emphasized the importance of training providers on 
how to respond to requests to perform FGM/C or reinfibulation, including how to manage the 
social or financial pressures to perform FGM/C.  
Participants from both high prevalence and diaspora countries described how 
understanding, but not endorsing, the perceived benefits of FGM/C may cultivate compassion 
and empathy in a health care provider, enabling them to more effectively counsel patients about 
health complications without stigmatizing the woman, her family, or her community.  
 
“. . . [an operating room nurse from an FGM/C practicing community upon seeing a 
Type 3 circumcision during a cesarian birth] said ‘This is so beautiful!” . . . that's when 
it really hit me that I need to honor women and really respect the value that they hold as 
it pertains to what's being done to their bodies that is not the Western lines of mutilation 
as we perceive of it.” (Female, Ob/GYN, Diaspora/ USA) 
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While participants uniformly agreed that FGM/C should not be performed, they cautioned that 
health care providers who hold strongly negative attitudes toward FGM/C risk stigmatizing and 
alienating their patients who find meaning and benefits in the practice.  
Participants agreed that providers must by knowledgeable about the health complications 
associated with FGM/C and their management, referencing the WHO Guidelines for the 
Management of Health Complications From FGM/C and WHO Clinical Handbook as excellent 
resources. Consistent with the WHO Clinical Handbook, participants reported that midwives and 
Ob/ Gyns must be knowledgeable about defibulation and other surgical procedures related to 
FGM/C (including indications and contraindications), and be able to perform them within their 
scope of practice.  
 
Attitudes Toward Providing FGM/C Care - Interactions with Knowledge and Practices 
Participants highlighted that health care provider attitudes toward providing FGM/C may 
be a barrier to knowledge acquisition and safe clinical practice. Participants described how 
complications of FGM/C may be a direct result of cutting or may be due to secondary 
complications resulting from provider mismanagement – a nuance not highlighted in the WHO 
Clinical Handbook. Failing to address a Type 3 infibulation scar during labor and birth was 
frequently mentioned. 
 
“Second might be prolonged because of soft tissue distortion. Someone might not be 
aware of how to manage the scar . . . they should treat early in the second stage [with 
defibulation] . . . if you delay, second stage might be prolonged and it's likely [the fetus 
is] disposed for perinatal asphyxia. (Male, Ob/ GYN, High Prevalence/ Ethiopia) 
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Mismanagement may be due to ignorance of evidence-based guidelines, or providers 
intentionally avoiding addressing FGM/C because it is unfamiliar, clinically difficult, or they are 
uncomfortable navigating the cultural and social implication of the plan of care. 
 
What about patients that request reinfibulation? But [some] providers have ethical or 
moral reasons that they don't want to honor that. So, providers end up offering a C-
section because they say, "Oh, at least we can avoid dealing with that scar.” (Female, 
Ob/GYN, Diaspora/ USA) 
 
WHO maintains health care providers should never perform reinfibulation; participants 
expressed more nuanced opinions. Participants from diaspora countries reported considerable 
moral distress around the opposition to reinfibulation as a cultural practice done in “other” 
countries compared to female cosmetic genital surgery performed in many Western countries. 
Some participants felt that, particularly following childbirth, that if a woman requests her vulva 
be repaired to approximate its appearance to match pre-childbirth/ pre-defibulation, that her 
wishes should be respected.  
 
“We should not be doing reinfibulation to re-create the original infibulation. Obviously 
not. [But] what about those women for whom genital self-image and their sense of 
familiarity . . . is with their vulva covered [by FGMC]? If a woman had healthy sexual 
function . . . why can't we honor her request to [close the] scar above the urethra? . . . 
Who are we to tell them we are not going to honor her request to restore her genital 
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anatomy that she's comfortable with? That's a double standard when you look at Western 
women who can drop $5,000 for trans-vaginal rejuvenation.” (Female, Ob/GYN, 
Diaspora/ USA) 
 
Participants from both diaspora and high prevalence countries highlighted the importance of 
making providers aware that requests for reinfibulation may occur. Participants expressed the 
importance of reflecting in advance on how to respond to patient requests in order to support 
individualized care, without violating the principle of Do no harm. Participants encouraged 
health care providers to clarify their own attitudes towards the care they will offer to empower 
them to navigate complex discussions with patients and their families. 
 
You have to counsel the patient about defibulation in advance [not] when the patient is in 
labor with her family all around. Her mother-in-law, her auntie, her grandmother, all 
these other matriarchal forces who may have different views on what she needs to do 
about her body . . . then you hear all the little clicks and heads shaking and fingers 
wagging from her family talking about, "No, you need to have it re-put back together” 
That's the reality. Women are not autonomous to make these decisions outside of the 
social and cultural framework of the matriarchal forces that are her social support. 
Being able to understand and navigate that dilemma is critical. (Female, Ob/ GYN, 
Diaspora/ USA) 
 
Participants cautioned that some providers may avoid FGM/C care when they feel that it 
is too difficult or complex. Those health care providers may be less empathetic and more likely 
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to dismiss complaints associated with FGM/C. The result may be patients that are less likely to 
discuss their concerns, particularly when she is already struggling to overcome a taboo to discuss 
FGM/C. 
 
I think FGM/C compounds that [difficulty communicating] . . . because . . . there's a 
taboo. You're not sure if your doctor is going to know what [FGM/C] is, whether they’ll 
be respectful or not. There's the added dread of bringing it up, and trusting their doctors 
to address it in a non-judgmental way. (Female, Family Medicine, Diaspora/ USA) 
 
The more [health care providers] show compassion the better. Even if [they] don't 
understand [FGM/C] and are shocked and horrified, I think managing these kinds of 
emotions would be important because otherwise, it's going to create more reluctance [for 
the patient] to say more. (Female, Anthropology, High Prevalence/ Sudan) 
 
Participants reported that health care providers often feel that they do not have time to 
address all of a patient’s concerns. Given limited time, providers who are less confident in their 
ability to address FGM/C related complaints or who believe it is not within their scope of 
practice, may avoid addressing FGM/C. Health care provider attitudes that result in avoiding 
discussion of  FGM/C may contribute to other secondary complications that include delays or 
dismissal of routine gynecologic care and procedures. Participants described that women living 
with FGM/C, particularly Type 3, may not be offered routine pap smears or experience delays in 
obtaining procedures such as endometrial biopsy because of difficulty of introducing a speculum 
into their vaginas. Also, participants simultaneously emphasized that women living with FGM/C 
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have the right to refuse recommended care without fear of retribution and should never be forced 
or coerced to undergo any genital exams or procedures.  
 
Attitudes Toward Women Living with FGM/C and Communities that Practice FGM/C 
Avoidance of FGM/C care may be exacerbated if health care providers believe 
stereotypes of about patients who have experienced FGM/C. Negative attitudes towards patients 
living with FGM/C include that they are ignorant or less educated, conservative or repressed 
(particularly related to sex and gender norms), or lack agency as passive victims.  
 
I think it's interesting how many people automatically seem to assume that the woman 
who has been circumcised is always a victim and that she lacks agency. I think that could 
potentially create problems. (Female, Medical Anthropology, Diaspora/ Sweden) 
 
They should not be looked upon as criminals or those who had been subjected to harmful 
practice because they're not responsible for this. When they were subjected to this 
practice, they were unable to give their consent. They were not aware about the 
procedure. They were never consulted about the procedure and consider they're victims. 
So, they need to be looked after. (Male, Ob/GYN, High Prevalence/ Egypt) 
 
Participants indicated that a health care provider’s belief that patients affected by FGM/C distrust 
health care providers, delay seeking care, or frequently refuse care can further a dynamic of 
mutual distrust. A health care provider’s mistrust of their patient may result in mistreatment, 
resulting in further patient mistrust of the health system.   
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“. . . if [a woman] goes and she doesn't get decent treatment, she is maltreated, she is 
stigmatized . . . [the doctor] starts passing unfriendly remarks . . . Of course, she will not 
go back again to the physician. She will not have access [to care]” (HPRH1019) 
 
Participants noted that it is the responsibility of the provider to earn the patient’s trust, and 
should not expect it be granted based on status as a health care provider. Participants highlighted 
that women who have undergone FGM/C are strong and empowered and may feel quite 
confident in their FGM/C status. These participants stressed positive attitudes toward patients 
can be cultivated by health care providers, thereby promoting increased patient-centered 
communication and shared decision-making. 
Participants described how some health care providers may have negative attitudes 
towards communities where FGM/C is a normative practice, and which may compromise quality 
of care through subtle or overt expressions of bias. Attitudes that communities that practice 
FGM/C are regressive or backward, or that they are strongly male-dominated/patriarchal with 
conservative gender norms, may lead health care providers to make assumptions about an 
individual patient. These assumptions can include preconceptions of how receptive she is to 
learning about FGM/C, what types of interventions she might consider, her plans for any girl 
children related to FGM/C, and the involvement from her partner or other family members. 
Some health care providers may believe that community commitment to FGM/C is immutable, 
and therefore not even worth fighting against, further leading the provider to avoid FGM/C 
discussions or health care. Participants stressed the importance of listening to each individual 
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patient and providing individualized patient-centered care based on her priorities, not 
preconceptions about her or her community. 
 
Attitudes Toward Ethical Issues in FGM/C Care – Adult and Pediatric Considerations 
Participants were consistently opposed to the practice of FGM/C, though their reasons varied. 
Some participants agreed with WHO that FGM/C is an unethical practice because it causes harm 
and therefore violates human rights and the medical ethical principle of Do No Harm.  Other 
participants believe that it is a child’s inability to legally consent to FGM/C as an elective 
surgical procedure is the main ethical objection rather than the possible health complications.  
 
When you perform female genital mutilation, most of the time, you perform it on a young 
girl she cannot give her consent. You're violating [her] autonomy. (Male, Ob/GYN, High 
Prevalence/ Egypt) 
 
For some, this leads to a stance against the genital cutting of any child, including male 
circumcision and gender assignment for those with ambiguous genitalia, because children cannot 
to consent to permanent bodily alterations. 
 
I wish that all children could grow up with their genitals intact until they are old enough 
to give consent to any procedure. (Female, Medical Anthropology, Diaspora/ Sweden) 
 
Following this argument, some participants felt that because adult woman are autonomous, they 
can consent to FGM/C. Some participants report that while they oppose the practice of FGM/C, 
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they feel the international opposition to the practice is problematic due to involvement of 
Western and White scholars from countries that permit elective cosmetic surgery, while 
condemning women of color who want genital alterations for cultural reasons.  
 
“There are some women [in the West] who want cosmetic surgery on their vagina. We 
get questions, ‘Why can women have their labia cut for a psychological reason and not a 
cultural reason?’ . . .  There are [minor] girls who claim that their labia are too long. 
They go to the doctors to cut them and they call it plastic surgery. The differentiation 
between that and wanting [FGM/C] for cultural issues is hard to defend because you 
totally ban the one operation and then you reimburse for the other. (DRH1203) 
Stances against male circumcision and support of adult women’s right to elect FGM/C, including 
reinfibulation, conflict with WHO and other international organization positions on FGM/C. 
Participants stressed the importance of educators and health systems providing education and 
training that includes reflection and ethical case discussion so that providers can consider their 
response to ethical issues while continuing to provide to patient-centered care. 
Participant interviews and the WHO Clinical Handbook were largely consistent with 
regards to knowledge and practices for pediatric care stressing the importance of appropriate 
screening and assessment and awareness of local requirements for reporting FGM/C cases. 
Pediatric or family provider participants highlighted the importance of receiving adequate 
training to perform pediatric genital examination for the identifications of FGM/C on an infant or 
young child because normal variation in genitals can appear to mimic Type 1 and 2 FGM/C. 
Providers without rigorous training might incorrectly report FGM/C. For participants in diaspora 
countries where parents can be convicted for subjecting a girl to FGM/C, participants discussed 
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the importance of awareness of mandatory reporting requirements for FGM/C cases identified 
during routine care, evidence of recent FGM/C, or suspected/planned vacation cutting. 
Participants described the ethical challenges facing pediatric providers who fear traumatizing 
children by risking family separation by reporting versus protecting them from FGM/C, which 
may result in immediate and long-term trauma and health complications. 
Pediatric providers in the diaspora discussed the importance of following a routine 
schedule for pediatric genital examination to ensure standard of care for all children and to avoid 
racial profiling of Black, immigrant and/or Muslim children by targeting them for genital exams. 
Diaspora pediatric providers highlighted the importance of communication skills when 
discussing FGM/C. Some immigrant adolescent girls may not have known they were 
circumcised.  
 
Health Care Provider Attitudes – Effects on Communication 
 Consistent with the WHO Clinical Handbook, Participants stressed that health care 
providers must be knowledgeable about how their verbal and non-verbal communication can 
impact clients who are living with FGM/C, and should be skillful in their application of patient-
centered communication practices. Participants further emphasized the importance of cross-
cultural communication, empathy, and humility during clinical care.  
“. . . number one is the patient-provider relationship. The ability to communicate with the 
patient, to build trust and have cultural humility . . . knowledge or skill, that's icing on the 
cake! Number one, you have to be able to engage with that patient and build her trust. 
Empathize with her and don't belittle her. See her as a human being with dignity and respect 
and have that cultural humility to say, "I want to learn. Teach me. Help me understand so I 
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can take the best care of you, and honor or whatever is important to you, so whatever you 
hold and value is dear. Let me help honor that for you and how can I help you." (Female, 
OB/ GYN, Diaspora/ USA) 
While the WHO Clinical Handbook does stress that health care providers should not stigmatize 
patients, study participants went further stating that health care providers must actively 
interrogate their own attitudes toward FGM/C, affected patients, and communities in order to 
avoid demonstrating shock, disgust, contempt, pity or other strong affective responses that may 
cause patients to feel stigmatized or ashamed.  
 
“If [a health care provider] looks down upon my community and then I would say, "No, 
you are not the right provider to give me care." . . . If I perceive you as not caring then 
why would I subject myself to [you] care? You wouldn't give me appropriate care, and I 
would perceive that your care is not well meant” (Female, Primary Care, High 
Prevalence/ Kenya)  
Participants stressed that health care providers must truly listen to women and avoid making 
assumptions about their beliefs, desires, families or communities.  
 
“It's a recognition that you don't know it all. You need to recognize that you're here to 
learn and that patients are themselves are the best teachers. If we let go of our 
preconceived notions . . . and say, "Can you teach me? Tell me what this means to you. 
Help me understand so I can provide better care. What does this mean to your family, to 
your husband? . . . Just help build trust in order to facilitate greater patient-provider 
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dialogue and engagement on a very taboo and very sensitive topic.” (Female, Ob/ GYN, 
Diaspora/ USA) 
Discussion 
Clinical and research experts for FGM/C described comprehensive areas of knowledge, 
attitudes and practices that contribute to high quality care for women and girls affected by 
FGM/C. Participants expressed viewpoints broadly consistent with the WHO Clinical Handbook 
with regards to the knowledge and practices that comprise quality care for those living with 
FGM/C. Participants agreed that knowledge about FGM/C as a practice, female sexual function, 
the health complications of FGM/C and their management, ethical and legal issues that may 
arise, and importance of communication are critical components of quality care for FGM/C. 
Participants described practice areas that were consistent with the WHO Clinical Handbook 
including patient intake and examination, management of complications, use of or referral for 
defibulation and other surgical interventions, pediatric care considerations, and delivery of 
patient-centered care. While the WHO Clinical Handbook does not directly address the impact of 
provider attitudes on the delivery of quality care, it does encourage providers to ask, listen, and 
reassure their patients during clinical care. There are also “Cultural Notes” throughout to bring 
attention to areas for cultural awareness and sensitivity.6 Participants discussed seven areas of 
attitudes that they note may affect quality of care for FGM/C including attitudes towards: 
benefits of FGM/C, harms of FGM/C, appropriate affective response to patients with FGM/C, 
providing FGM/C care, ethical considerations, women who have undergone FGM/C, and 
communities the practice FGM/C. 
Participants discussed additional areas of knowledge, attitudes and practices that were not 
included, or provided a different emphasis, in the WHO Clinical Handbook. Additional areas of 
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knowledge highlighted by participants as important for quality care include: unaltered female 
genital anatomy and physiology, secondary harm health care providers may cause by failing to 
address or mismanaging FGM/C, and the impact of provide affect and bias. Participants 
emphasized that providers must practice patient-centered communication skills, and be aware of 
how their own affective response (including verbal and non-verbal) may communicate 
stigmatizing attitudes and bias that may affect the quality of care delivered, and the patient. This 
theme is consistent with research that demonstrates the health care provider bias negatively 
affects quality of care, and can worsen patient health outcomes.46,47  
Participants described how health care provider knowledge is an important precursor to 
practice, but that provider attitudes may intervene in the pathway between knowledge and 
practice influencing the quality of care that is delivered. Participants described additional areas 
of practice that were not discussed in the WHO Clinical Handbook, but that were closely tied 
with provider attitudes. Participants discussed the importance of judicious use of interventions –
that providers offer appropriate interventions to improve outcomes, but do not offer excess 
interventions. Participants described how health care provider discomfort with FGM/C care, 
belief that FGM/C care is too difficult or not their responsibility, may be more likely to over or 
underuse interventions. Qualitative research with providers has similarly found that when they 
are unsure of the best practice for care, they will tend to improvise a treatment or ignore the 
complaint.30 For example, studies have documented that women with FGM/C, particularly Type 
3 FGM/C, have higher rates of cesarean birth.48–50 Participants discussed that it is unclear if these 
excess cesareans are due to the FGM/C, which in most cases would result only in an outlet 
obstruction of the vulva that could be resolved quickly with defibulation, to lack of provider 
knowledge about defibulation, or because the provider simply wanted to avoid addressing the 
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scar and thus proceeded to cesarean birth. Participants reflected that even providers who are 
aware of defibulation may decline to perform the procedure in order to avoid discussion around 
reinfibulation after childbirth.  
In order to ensure that patients receive high quality care, health care providers must develop 
awareness of their own attitudes toward FGM/C and the women and communities affected by the 
practice, clarify their position on ethical dilemmas that may arise during clinical practice, and 
remain mindful of their affective response to avoid stigmatizing the patient. It is encouraging to 
note that women with FGM/C who experience care where they feel valued and understood are 
more likely to favorably engage with preventative health services.51 
The results of our study can guide the development of comprehensive training curricula 
for health care providers. We identified two studies that assess the effectiveness of existing 
health care provider trainings for FGM/C conducted in Mali and the USA respectively; however, 
neither used validated assessment measures or control groups, nor did they present 
comprehensive curriculum that could be replicated.52,53 Future trainings should include content 
from the WHO Clinical Handbook, and the additional areas of knowledge, attitudes, and practice 
that emerged from this study. Study participants discussed how health care provider attitudes 
may influence how they receive and integrate content of training interventions aimed to improve 
knowledge or transform clinical practice. 
In order to effectively address knowledge, attitudes and practices, future trainings should 
include multiple delivery methods. Lectures and reading are effective methods for transmitting 
knowledge. Simulation is an effective training methodology for increasing health care provider 
confidence for the provision of care, particularly for care that is either higher acuity or seen 
irregularly in clinical practice.54,55 Ethical issues around FGM/C may be taught through case 
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studies and interactive discussions which encourage learners to engage in critical self-reflection, 
to articulate their own attitudes or opinions, and reflect upon how they as a provider may impact 
how a patient experiences the quality care she receives.56  
To our knowledge, there are no validated measures of health care provider knowledge, 
attitudes, and practices. Measures that do exist lack a clear framework defining each domain 
undermining the validity of the measures, and include inconsistent items limiting the 
comparability of findings.44 The framework of knowledge, attitudes, and practices that we 
developed during the qualitative analysis should be used to inform the development of 
psychometrically validated measures to assess health care provider knowledge, attitudes and 
practices for FGM/C care. We plan to utilize the themes and subdomains within knowledge, 
attitudes, and practices that we identified during the Framework analysis to create a 
comprehensive item bank. This large item bank would then be pilot tested in one or more 
countries using rigorous psychometric methods to create a valid and reliable measure of health 
care provider knowledge, attitudes and practices. A future measure based on this qualitative data 
would allow researchers to explore the hypotheses presented by many of our study participants; 
namely, that health care provider attitudes affect the relationship between knowledge and 
practice. Researchers could then also explore how different provider, provider family, clinical 
setting, community or societal level factors affect health care provider knowledge, attitudes, and 
practices. By better understanding how health care provider attitudes affect knowledge and 
clinical practice, health educators and health systems continually refine trainings to address these 
key intersections.  
Our study had many strengths and like any study, some limitations as well. Our study 
population includes a broad sample of clinical and research experts representing a diversity of 
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clinicians and researchers, disciplinary perspectives, and regions, which contributes to the 
trustworthiness of our study.  We used a rigorous and targeted methodology for qualitative 
analysis and an appropriate theoretical framework to guide our study. However, we only 
conducted interviews with recognized experts who were available to speak or communicate via 
phone or internet. There may be additional expertise from clinicians and researchers working in 
more rural and less accessible areas that would further expand our understanding of critical 
knowledge, attitudes and practices. We conducted interviews only in English or French, 
excluding the perspective of those who do not speak those languages. By focusing on established 
experts in FGM/C, we may be missing the perspectives of more front-line health workers. 
Experts in our sample had minimal experience in Asia, so information on FGM/C in that region 
may be underrepresented. 
 
Conclusion 
Study participants included global researcher and clinician experts in FGM/C who 
described comprehensive areas of knowledge health care providers require in order to provide 
effective health care to women and girls affected by FGMC, attitudes that may facilitate or 
impede the provision of high-quality health care, and the clinical practices that comprise safe, 
efficient, and accessibly care. The broad depth and breadth expressed in the qualitative research 
provides rich data from which to create comprehensive health care provider trainings, and to 
inform the development of a comprehensive assessments of health care provider knowledge, 
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CHAPTER 5: SYNTHESIS/DISCUSSION 
Introduction 
FGM/C is a significant public health issue that most health care providers are not 
adequately trained to address. This dissertation presents the first psychometrically validated 
measures of health care provider attitudes and confidence for the care of women and girls living 
with FGM/C in the US context, and findings from a qualitative exploration of global expert 
opinion on the knowledge, attitudes and practices that contribute to quality care for women and 
girls living with FGM/C globally. In order to construct the measures to assess health care 
provider attitudes and confidence, we conducted a comprehensive review of existing attitudes 
and confidence measures and guidelines for FGM/C care from global professional organizations, 
and utilized a conceptual approach to guide the item development. We then applied rigorous 
psychometric analyses to assess the reliability and validity of these novel measures of health care 
provider attitudes and confidence for the care of women and girls living with FGM/C in the 
USA. The psychometric analysis of our newly developed measures of attitudes and confidence 
resulted in four subscales: Negative Attitudes toward FGM/C, Empathetic Attitudes toward 
FGM/C, Confidence in Clinical FGM/C Care and Confidence in Critical Communication Skills 
for FGM/C Care. While the measures demonstrated adequate reliability, the validity testing 
highlighted some limitations; they may be improved with additional research. Future iterations of 
these subscales may include the addition of more items to increase the depth and breadth of 
attitudes and confidence that are assessed.  
The qualitative portion of this study addressed the aim of advancing our understanding of 
the knowledge, attitudes, and practices that clinical and research experts for FGM/C agree are 
important for the provision of quality care to those living with FGM/C globally. This formative 
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research will inform the development of comprehensive training curricula, revisions and updates 
to existing guidelines establishing standard of care, and the construction of a comprehensive 
measure of knowledge, attitudes, and practices for use in the USA and globally.  
 
Summary of Findings by Specific Aim 
Specific Aim 1 
Utilize exploratory factor analysis to assess the factor structure and psychometric 
properties of the newly developed attitudes and confidence scales. Further, assess the concurrent 
validity of the attitudes and confidence scale by testing the hypotheses that known groups would 
have significantly different scores on the respective scales.  
We used exploratory factor analysis (EFA) for the psychometric assessment of both the 
attitudes and confidence scales. The exploratory factor analysis (EFA) revealed a two-factor 
solution for the attitudes scale, including subscales for Negative Attitudes and Empathetic 
Attitudes toward FGM/C and those who practice FGM/C. We assessed the reliability of the 
subscales using Cronbach’s alpha. The Negative Attitudes subscale had a Cronbach’s alpha of 
0.814 demonstrating good reliability, while the Empathetic Attitudes subscale had an alpha of 
0.628 which is at the lower end of acceptable reliability for a newly developed scale.  
We assessed the validity of the subscales by comparing scores of known groups that we 
hypothesized would have significantly different scores. We hypothesized that health care 
providers who have ever cared for someone who had experienced FGM/C, received training for 
FGM/C care, or practice in a women’s health specialty would have less negative and more 
empathetic attitudes toward FGM/C; however, there was no significant difference in scores for 
these groups. This may be because we used a convenience sample of health care providers who 
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were motivated enough to dedicate time to register for a training on FGM/C and complete an 
optional survey. These providers may have more similar attitudes toward FGM/C based on their 
interest in caring marginalized group than a random sample of health care providers. Nursing and 
mental health providers had significantly more empathetic and less negative attitudes toward 
FGM/C and those who practice compared to licensed independent providers confirming our 
hypothesis members of professions whose training includes the inter-personal expression of 
empathy as a critical skill (such as nursing and mental health) demonstrate those attitudes more 
strongly. Women and people of color did have significantly less negative attitudes toward 
FGM/C compared with men and whites, respectively confirming our hypothesis that shared lived 
experience of gender or as a person of color who may be more likely to have experienced bias in 
the health care setting as a clinician or patient who resulting in less negative attitudes.  
The validity and reliability of the attitude subscales may have been further limited by a 
lack of variance in participant scores. Participants tended to select agree/ disagree, while 
selecting strongly agree or strongly disagree with the statements rarely – particularly for the 
empathetic attitude subscale. Further, a number of items on both subscales had >80% of 
participants endorsing agree/ strongly agree or disagree/ strongly disagree. The subscales may 
require further revision of existing items, and benefit from the inclusion of additional items that 
capture a wider breadth of empathetic and negative attitudes toward FGM/C and those who 
practice. Further, our scale would benefit from the addition of items that assess attitudes towards 
providing care to patients who have experienced FGM/C. The qualitative interviews highlighted 
that attitudes toward the provision of care may impact quality of care delivered, and may be 
unrelated to how negative or empathetic health care provider attitudes toward FGM/C and those 
 116 
affected by the practice are. Future iterations of the attitude scales should include additional 
items, and undergo further psychometric testing in a random sample of health care providers.  
The EFA for the confidence scales also revealed a two-factor solution including 
Confidence in Clinical FGM/C Care and Confidence in Critical Communication Skills for 
FGM/C Care. We assessed reliability using Cronbach’s alpha, which demonstrated coefficients 
of 0.857 and 0.694 for the Confidence in Clinical FGM/C Care and Confidence in Critical 
Communication Skills for FGM/C Care subscales, respectively. The lower reliability for the 
Confidence in Critical Communication Skills for FGM/C Care may be due to a combination of 
factors. This subscale only includes 3-items, which can affect the Cronbach’s alpha. Participants 
scores on these items also had limited variance with participants generally rating their 
communication skills highly. This again may be due to similarities within our convenience 
sample of health care providers who sought out additional training for the care of a marginalized 
population. They may have more experience in the skills assessed, such as conducting care via 
an interpreter, compared with a random sample of health care providers. It is also possible that 
while health care providers are highly confident in their communication skills, their patients may 
perceive the communication differently. Existing qualitative research with women who have 
experienced FGM/C demonstrates that many experience bias, stigma, and discrimination. Future 
iterations of the communication subscale should include review and consultation with women 
who have experienced FGM/C. Future research that compares provider self-rated confidence in 
communication and patient experiences of communication could further inform scale 
development.  
 
Specific Aim 2 
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Explore the relationship between health care provider demographic characteristics, previous 
clinical experience related to FGM/C, awareness of health complications associated with 
FGM/C, attitudes towards FGM/C and those who practice FGM/C, and confidence for the care 
of women and girls affected by FGM/C. 
Health care providers in our sample were aware of the majority of health complications 
associated with FGM/C; however, our sample was self-selected and may not be representative of 
health care providers in the US. Studies that have assessed health provider knowledge of FGM/C 
in the US have found that health care providers often have inadequate knowledge about FGM/C 
to provide quality care.1–3 Though knowledge about FGM/C care tends to be low among sampled 
USA providers, one study of USA midwives did find that 70-90% were aware that FGM/C does 
result in health complications.4 Factors associated with increased awareness of health 
complications included having ever care for a woman with FGM/C or ever having received 
training related to FGM/C.  
Health care providers in our sample tended to score toward the higher end of the Negative 
Attitudes scale indicating more negative attitudes. This finding was consistent with existing 
literature from women and girls with FGM/C who report that they feel health care providers 
often stigmatize them based on their FGM/C status.5,6 Scores on the Empathetic Attitudes scale 
fell were on average around the mid-range of scale, which may indicate more ambivalence 
around the statements that empathize with FGM/C. This finding is consistent with qualitative 
literature that has found health care providers experience a tension between strongly negative 
attitudes toward FGM/C as a practice, and pity or concern for the woman who has undergone 
FGM/C.7  The only statistically significant factor associated with either attitudes score was that 
health care providers who are women had significantly less Negative Attitudes toward FGM/C 
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compared with men. A study conducted in Spain found that health care providers who are men 
were more likely that women to report women with FGM/C to the authorities further indicating 
that health care provider gender may influence the care that is provided.8 
 Health care providers in our sample scored an average of 11.48 (possible range 5-20) on 
the Confidence for Clinical FGM/C Care scale indicating a moderate level of confidence. 
Factors associated with provider’s reporting higher Confidence for Clinical FGM/C Care include 
awareness of health complications, ever cared for a woman with FGM/C, being a woman, 
identifying as a person of color, and clinical experience of 5 or more years. Qualitative literature 
inform these findings by confirming that health care providers are often not confident regarding 
what constitutes quality care for FGM/C, and thus not confident in their ability to provide it.7,9,10  
A recent study in Australia found that health care providers generally lack the knowledge, 
training, and competency to provide sexual and reproductive health for refugee and migrant 
women in general, despite sexual and reproductive health being part of mainstream clinical 
competencies.11 Given that our sample included a convenience sample of health care providers 
who self-selected participation, they may in fact have higher confidence for FGM/C clinical care 
compared to the general population of providers in the USA due to their interest in the topic of 
FGM/C and serving a diverse population of women.  
At the time of this study, there were no USA professional organizations with published 
practice guidance on the care of women and girls living with FGM/C which may contribute to 
our findings that health care providers lack confidence for the care of FGM/C affected 
populations. A review conducted in 2019 found that of 47 professional organizations for health 
care providers in the USA, only 51% have any statement related to FGM/C and only 17 made 
any statement of the role of the clinician in FGM/C care. Those that did discuss clinician role 
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varied considerably in tone and instructional content.12 Since publication, the American 
Academy of Pediatrics has published a Clinical Report for FGM/C care in girls.13In 2018, around 
the time we began data collection for this study, the WHO published Care of Women and Girls 
Living with FGM: A Clinical Handbook, which does provide comprehensive information for 
clinical care.14  
Health care providers in our sample scored an average of 9.08 (possible range 3-12) on 
the Confidence in Critical Communication Skills for FGM/C Care scale. The only factor 
associated with increased Confidence in Critical Communication Skills for FGM/C Care was 
awareness of health complications for FGM/C. The higher level of provider Confidence in 
Critical Communication Skills for FGM/C Care is more surprising in context of qualitative 
literature with patients with FGM/C who report experiencing stigma, disrespect, and bias in the 
clinical setting.6,15 Having received FGM/C training was not associated with increases in 
confidence for either clinical care or communication skills suggesting that existing trainings are 
not adequate to prepare providers to care for women and girls affected by FGM/C. Future 
trainings should include multiple training modalities including simulation, standardized patients, 
and pelvic training surgical models to ensure that health care providers have opportunities to 
build confidence in their clinical and communication skills, while also reflecting upon the ways 
their attitudes may influence care provision.  
 
Specific Aim 3 
Explore the knowledge, attitudes, and practices that global clinical and research experts 
in FGM/C consider important to ensure high quality, safe, and effective care for FGMC-affected 
women and girls using qualitative in-depth individual interviews. 
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Participants identified six subdomains of knowledge that are important for the delivery of 
quality health care for FGM/C affected clients including general FGM/C knowledge, unaltered 
female genitalia, health complications, management of health complications, ethical and legal 
considerations, and the role of communication in quality of care. Within each subdomain of 
knowledge, we highlighted additional themes that emerged. 
Figure 13 Knowledge Subdomains and Themes 
 
Participants identified six domains of health care provider practice that constitute quality care to 
women and girls affected by FGM/C including clinical procedures and protocols, management of 
complications, defibulation, additional surgical procedures, pediatric care, and patient-centered 
care and communication. Within each subdomain of practice, we highlighted additional themes 
that emerged. 
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Figure 14 Practices Subdomains and Themes 
 
Most of the subdomains and themes that emerged for knowledge and practice were also included 
in the WHO Clinical Handbook; however, there were a number of themes that emerged in the 
qualitative interviews that either did not appear in the WHO Clinical Handbook, or where the 
emphasis differed meaningfully noted in bold.  
Participants identified seven areas of attitudes that health care providers must reflect on 
to provide quality care: attitudes towards the benefits and harms of FGM/C, attitudes toward 
providing care for clients affected by FGM/C and how these attitudes may influence provider 
affective response to a patient, attitudes toward women and girls who have experienced FGM/C 
and the communities that practice FGM/C, and attitudes towards various ethical issues that may 
arise in the course of caring for patients with FGM/C. 
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Figure 15 Attitudes Subdomains and Themes 
 
Study participants expanded upon the knowledge, attitudes, and practices described in the WHO 
Clinical Handbook by including not just the biomedical processes of diagnosis and treatment, but 
emphasized that knowledge about the impact of one’s interpersonal communication skills and 
practice of patient-centered communication further promote high quality care for FGM/C. A 
recent qualitative systematic review of healthcare experiences of women who have undergone 
FGM/C found that many experience cultural dissonance and feel disempowered during care due 
to the poor communication skills of health care providers, challenges compounded by language 
barriers, cultural taboos around discussing FGM/C, and health care providers who are hesitant to 
broach the topic.15 Future trainings and guidelines for health care provider should emphasize 
health care provider responsibility to gain the communication skills and confidence to address 
FGM/C and sexual health in a respectful and patient-centered manner. Study participants further 
stressed that a strong foundational knowledge of unaltered female genital anatomy and 
physiology should be part of training for FGM/C because many providers lack this knowledge 
which is critical to understanding how the cutting may impact a woman’s health outcomes. The 
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knowledge, attitudes and practices identified by participants as contributors to quality care can be 
compared to findings from a recent systematic review that explored factors influencing nurses 
provision of sexual healthcare education: lack of knowledge, attitudes and beliefs that sexual 
health care is private and not a priority for the provider, discomfort addressing sexual health, and 
perceived barriers to providing care in the clinical setting.16 
Study participants stressed that health care provider attitudes are an important contributor 
to quality of care. There is evidence that members of disadvantaged and marginalized groups, 
including immigrants, people of color, and people with low-English proficiency experience 
discrimination and bias during clinical care, and that these experiences result in worse health 
outcomes across a number of diseases and conditions.17,18 Attitudes may influence how receptive 
providers are to training interventions that aim to increase knowledge and transform clinical 
practice, highlighting the importance of transforming health care provider education in order to 
dismantle systems and attitudes that contribute to bias, racism, and discrimination.19 Attitudes 
may affect the quality of communication during clinical encounters in myriad ways that can 
promote or undermine the delivery of quality care for FGM/C affected clients therefore health 
care providers must receive communication skills training the aims to reduce or eliminate 
damaging attitudes and expressions of bias.20 Health care providers must also have the insight 
and capacity for introspection to acknowledge that such a problem exists. Further research is 
urgently needed to explore how to best promote self-reflection and attitude change among health 
care providers. 
The expanded domains of knowledge, attitudes, and practices may be use to inform 
future revisions of the WHO Clinical Handbook, and to inform the development of training 
curricula for FGM/C care. Health care providers, health educators, and health systems must 
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create mechanisms for reflection, discussion and transform of attitudes to promote quality of care 




The findings from our survey and qualitative exploration indicated that health care 
provider require training to increase knowledge, transform clinical practice, increase confidence 
and cultivate patient-centered attitudes in order to provide quality care to women and girls who 
have experienced FGM/C. Nursing, midwifery, and medical educators must ensure that their 
curricula address the care of FGM/C affected women and girls. Training should provide didactic 
content to provide a comprehensive knowledge base about what constitutes effective care for 
FGM/C, clinical practice training to increase confidence and establish expectations for the 
provision of quality clinical care, and opportunities for identification, discussion, and reflection 
on attitudes held toward FGM/C and those who practice FGM/C.  Health educators can support 
improved clinical practice by offering simulation based educational opportunities which has been 
shown to be effective in developing health care provider confidence, particularly for low 
frequency events such as FGM/C care in the USA, and may better influence future performance 
of the target practice.21,22  Health educators should integrate structured simulated patient 
encounters to support communication skills training, addressing ethical issues during clinical 
care, and to practice patient-centered communication. Structured simulation has been shown to 
be an effective strategy to improve communication, empathy and self-efficacy for nursing 
students.23 Communication skills training is important to promote respectful, equitable and 
patient-centered care.  
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All health care providers, and especially those who care for marginalized and under-
served groups such as immigrants and refugees, people of color and/or cultural/ ethnic 
minorities, and those with low-English proficiency need to be aware of the adverse effects that 
bias and discrimination may have on patient outcomes. In order to achieve sustained attitude 
transformation and behavior change, health care providers, educators and institutions must 
develop a culture of accountability that demands health care providers develop an awareness of 
their own attitudes, and promote patient-centered care for women and girls affected by FGM/C 
and all marginalized populations. Our research has further demonstrated that on-going training is 
critical as health care providers with more years of experience may express less empathy 
compared with newer providers. Further, it is critical that the health care workforce overall more 
closely reflects the populations that we serve in terms of racial, ethnic, gender, and other 
identities. Cultural congruence between health care providers and patients has been demonstrated 
to improve quality of care, markers of communication, and health outcomes for marginalized 
patients. Health care providers must receive comprehensive and on-going training to identify 
their attitudes, and mitigate or eliminate expressions of bias and discrimination in health care.24,25 
 
Policy Implications  
  
Professional organizations for health care providers including nurses, midwives and 
physicians should ensure that the care of women and girls living with FGM/C are included as 
part of the core competencies, and that curricula are integrated into these training programs. 
Additional modules should be created for expanded scope of practice for health care providers 
who attend births including midwives, obstetricians and family medicine physicians for the 
management of FGM/C during labor and birth, including surgical defibulation. The American 
 126 
College of Nurse-Midwives (ACNM), American Academy of Family Physicians (AAFP), 
American Academy of Pediatrics, and the American College of Obstetricians and Gynecologist 
(ACOG) have issued policy statements about FGM/C that affirm their opposition to the practice, 
and outline of basic competencies FGM/C care. However, these organizations should go further 
and develop Clinical Practice Guidelines that providers can reference for the provision of quality 
care. Neither the Association of Women’s Health, Obstetric and Neonatal Nurses (AWOHNN) 
nor the American Academy of Nurses (AAN) have published any policy or guidelines related to 
FGM/C. These professional organizations for nurses, midwives, and physicians should not only 
issue policy statements regarding the practice, but also Clinical Practice Guidelines that are 
specific to each respective scope of practice so that health care providers can quickly access 
resources to ensure they provide quality care.  
 
Recommendations for Future Research 
 
The newly validated measures to assess health care provider attitudes and confidence 
represent an important advancement in the assessment of health care providers for the care of 
women and girls living with FGM/C. Assessing health care provider attitudes and confidence for 
FGM/C care is important because qualitative and quantitative literature indicate that these factors 
influence the quality of care women experience.6,26,27 Future research can explore how health 
care providers attitudes and confidence are related to clinical practice, and patient perceptions of 
quality of care, particularly patient-centeredness. These measures are the first psychometrically 
validated measures to assess care providers for the care of women and girls living with FGM/C. 
They have been developed for use in the USA, and would require further validity testing for use 
in other settings. The attitudes scale in particular did not have strong concurrent validity within 
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the sample population of US providers in Baltimore and Phoenix areas. This may be because our 
sample included a self-selected group of health care providers who possibly share an interest in 
FGM/C and immigrant/ refugee health, and thus potentially more likely to share similar attitudes. 
The attitudes scales should be further refined by including additional items to assess a wider 
range of attitudes toward FGM/C. Future research should test additional variables such as 
measures of implicit bias, and cultural competency as possible correlates of attitudes to further 
evaluate the validity of the instrument. 
 Our qualitative research demonstrated an expanded understanding of the knowledge and 
practices that constitute quality of care, and the attitudes that may affect quality of care provided 
to those living with FGM/C. The framework developed through the qualitative analysis including 
subdomains and themes within with respect domain of knowledge, attitudes, and practices should 
inform the development of a more comprehensive KAP measure. An important limitation of our 
study was the lack of patient perspectives. Further development of the KAP framework for 
FGM/C care should include the perspective of women and girls who have experienced FGM/C. 
They may have different insights related to both the areas of knowledge, attitudes and practices 
that are critical for quality of  care for FGM/C, and understanding of how they affect their lived 
experience of care. The qualitative interviews would be used for formulate a comprehensive item 
bank that would include items with a broader depth and scope of the instrument we developed 
for use in the USA. Our attitudes measure included thirteen items addressing attitudes towards 
FGM/C, women who have experienced FGM/C, and communities that practice. A more 
comprehensive item bank would include all the subdomains and themes identified during the 
Framework analysis of the qualitative data, including attitudes toward ethical issues that may 
arise during FGM/C care. This future KAP instrument could be tested with a global sample of 
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health care providers for use in multi-country settings.  This would allow for a more rigorous 
assessment of health care providers and inform country or region-specific training needs 
interventions aimed at improving quality of care for FGM/C, and patient outcomes related to 
FGM/C. A KAP instrument to explore relationships among health care provider characteristics, 
knowledge, attitudes and practices for the care of women and girls affected by FGM/C. The 
finding from both our US study, and the qualitative exploration of expert opinion, highlight that 
health care providers are not adequately trained to care for women and girls living with FGM/C. 
The finding from both phases of our study can inform the development of training curricula for 
health care providers that incorporate delivery of didactic content to increase knowledge, 
simulation activities to improve clinical practice and confidence, and case-based discussions to 
explore one’s attitudes towards FGM/C and the ethical issues that may arise while providing care 
for those affected.  
 
Conclusion 
 This research experience gave me the opportunity to explore how we assess health care 
providers who care for women and girls living with FGM/C. Through the collaborative research 
process with the team at Arizona State University, we were able to construct and assess the 
reliability and validity of instruments to measure health care provider attitudes and confidence. 
By applying rigorous psychometric methods to the assessment of these instruments, we have 
demonstrated both that they can be used for reliable assessment and that there is room for 
improvement. The qualitative study further expanded our understanding of the knowledge and 
practices that constitute quality care for women and girls living with FGM/C, and the ways in 
which attitudes may affect the quality of care that is actually delivered. Our research highlighted 
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the importance of training for all health care providers for the care of women and girls living 
with FGM/C. While the transmission of adequate knowledge about effective care for FGM/C, 
and the safe, accessible and efficient delivery of care are critical to the provision of quality care, 
they are not sufficient. Health care providers must also actively reflect on their own attitudes, 
engage in discussions and values clarification around ethical issues that may arise, and commit to 
providing care that is patient-centered and equitable. Health educators and professional 
organizations must ensure that all health care providers undergo trainings that encourage 
reflection and transformation of bias and discrimination. This might include structured 
evaluation during training of core competencies related to communication, and mandatory 
continuing education activities such as simulation, standardized patient encounters, and 
structured case discussions that explore stigma, discrimination and bias affecting marginalized 
and underserved populations. Our KAP framework and qualitative research can inform the 
development of a more comprehensive assessment instrument of knowledge, attitudes, and 
practices that may be used to evaluate the effectiveness of future trainings – further contributing 
the optimization of care for women and girls living with FGM/C. 
 
References 
1.  Lane JL, Johnson-Agbakwu CE, Warren N, Budhathoki C, Cole EC. Female Genital 
Cutting: Clinical knowledge, Attitudes, and Practices from a Provider survey in the US. J 
Immigr Minor Heal. 2018;0(0):0. doi:10.1007/s10903-018-0833-3 
2.  Young J, Knuti K, Basel R, Agbakwu CJ. Female Genital Mutilation / Cutting — 
Pediatric Physician Knowledge , Training , and General Practice Approach American 
Academy of Pediatrics. J Immigr Minor Heal. 2019. doi:10.1007/s10903-019-00938-x 
3.  Jacoby SD, Smith A. Increasing certified nurse-midwives’ confidence in managing the 
obstetric care of women with female genital mutilation/cutting. J Midwifery Women’s 
Heal. 2013;58(4):451-456. doi:10.1111/j.1542-2011.2012.00262. 
4.  Hess RF, Weinland J, Saalinger NM. Knowledge of female genital cutting and experience 
with women who are circumcised: a survey of nurse-midwives in the United States. J 
Midwifery Womens Health. 2010;55(1):46-54. doi:10.1016/j.jmwh.2009.01.005 
 130 
5.  Pavlish CL. Somali Immigrant Women and the American Health Care System. Soc Sci 
Med. 2010;71(2):353-361. doi:10.1016/j.socscimed.2010.04.010.Somali 
6.  Hamid A, Grace KT, Warren N. A Meta-Synthesis of the Birth Experiences of African 
Immigrant Women Affected by Female Genital Cutting. J Midwifery Womens Health. 
2018:1-11. doi:10.1111/jmwh.12708 
7.  Ogunsiji O. Australian midwives’ perspectives on managing obstetric care of women 
living with female genital circumcision/mutilation. Health Care Women Int. 
2016;37(10):1156-1169. doi:10.1080/07399332.2016.1215462 
8.  Kaplan A, Torán-Monserrat P, Moreno-Navarro J, Castany Fàbregas MJ, Muñoz-Ortiz L. 
Perception of primary health professionals about female genital mutilation: from 
healthcare to intercultural competence. BMC Health Serv Res. 2009;9:11. 
doi:10.1186/1472-6963-9-11 
9.  Dawson AJ, Turkmani S, Varol N, Nanayakkara S, Sullivan E, Homer CSE. Midwives’ 
experiences of caring for women with female genital mutilation: Insights and ways 
forward for practice in Australia. Women Birth. 2015;28(3):207-214. 
doi:10.1016/j.wombi.2015.01.007 
10.  Dawson A, Homer CSE, Turkmani S, Black K, Varol N. A systematic review of doctors’ 
experiences and needs to support the care of women with female genital mutilation. Int J 
Gynaecol Obstet. 2015;131(1):35-40. doi:10.1016/j.ijgo.2015.04.033 
11.  Mengesha ZB, Perz J, Dune T, Ussher J. Preparedness of health care professionals for 
delivering sexual and reproductive health care to refugee and migrant women: A mixed 
methods study. Int J Environ Res Public Health. 2018;15(1). doi:10.3390/ijerph15010174 
12.  Choudhary I, Mishori R, Kim S. Words Matter: Charting the Landscape of US and 
International Health Profession Organizations’ Public Statements About FGM/C. J 
Immigr Minor Heal. 2019;21(4):893-904. doi:10.1007/s10903-018-0818-2 
13.  Young J, Nour NM, Macauley RC, Narang SK, Johnson-Agbakwu C. Diagnosis, 
management, and treatment of female genital mutilation or cutting in girls. Pediatrics. 
2020;146(6). doi:10.1542/peds.2020-1012 
14.  WHO. WHO | Care of Girls and Women Living with Female Genital Mutilation.; 2018. 
http://www.who.int/reproductivehealth/publications/health-care-girls-women-living-with-
FGM/en/. 
15.  Evans C, Tweheyo R, McGarry J, et al. Seeking culturally safe care: A qualitative 
systematic review of the healthcare experiences of women and girls who have undergone 
female genital mutilation/cutting. BMJ Open. 2019;9(5). doi:10.1136/bmjopen-2018-
027452 
16.  Fennell R, Grant B. Discussing sexuality in health care: A systematic review. J Clin Nurs. 
2019;28(17-18):3065-3076. doi:10.1111/jocn.14900 
17.  Fitzgerald C, Hurst S. Implicit bias in healthcare professionals: A systematic review. BMC 
Med Ethics. 2017;18(1). doi:10.1186/s12910-017-0179-8 
18.  P. Goddu A, O’Conor KJ, Lanzkron S, et al. Do Words Matter? Stigmatizing Language 
and the Transmission of Bias in the Medical Record. J Gen Intern Med. 2018;33(5):685-
691. doi:10.1007/s11606-017-4289-2 
19.  Burnett A, Moorley C, Grant J, et al. Dismantling racism in education: In 2020, the year 
of the nurse & midwife, “it’s time.” Nurse Educ Today. 2020;93:104532. 
doi:10.1016/j.nedt.2020.104532 
20.  Hagiwara N, Elston Lafata J, Mezuk B, Vrana SR, Fetters MD. Detecting implicit racial 
 131 
bias in provider communication behaviors to reduce disparities in healthcare: Challenges, 
solutions, and future directions for provider communication training. Patient Educ Couns. 
2019;102(9):1738-1743. doi:10.1016/j.pec.2019.04.023 
21.  Warren JN, Luctkar-Flude M, Godfrey C, Lukewich J. A systematic review of the 
effectiveness of simulation-based education on satisfaction and learning outcomes in nurse 
practitioner programs. Nurse Educ Today. 2016;46:99-108. 
doi:10.1016/j.nedt.2016.08.023 
22.  Williams D, Rhodes RE. The Confounded Self-Efficancy Construct: Review, Conceptual 
Analysis, and Recommendations for Future Research. Health Psychol Rev. 
2016;10(2):113-128. doi:10.1080/17437199.2014.941998 
23.  Li J, Li X, Gu L, et al. Effects of simulation-based deliberate practice on nursing students’ 
communication, empathy, and self-efficacy. J Nurs Educ. 2019;58(12):681-689. 
doi:10.3928/01484834-20191120-02 
24.  Hall WJ, Chapman M V., Lee KM, et al. Implicit racial/ethnic bias among health care 
professionals and its influence on health care outcomes: A systematic review. Am J Public 
Health. 2015;105(12):e60-e76. doi:10.2105/AJPH.2015.302903 
25.  White-Davis T, Edgoose J, Brown Speights JS, et al. Addressing racism in medical 
education: An interactive training module. Fam Med. 2018;50(5):364-368. 
doi:10.22454/FamMed.2018.875510 
26.  Dawson A, Homer CSE, Turkmani S, Black K, Varol N. A systematic review of doctors’ 
experiences and needs to support the care of women with female genital mutilation. Int J 
Gynecol Obstet. 2015;131(1):35-40. doi:10.1016/j.ijgo.2015.04.033 
27.  Turkmani S, Homer CSE, Dawson A. Maternity care experiences and health needs of 
migrant women from female genital mutilation–practicing countries in high-income 





Appendix A - Quantitative Survey 


































































































































Hemorrhage	 	 	 	 
Pain	 	 	 	 
Hemorrhagic,	neurogenic	or	septic	
shock	 
	 	 	 
Genital	tissue	swelling	 	 	 	 
Genital	and	reproductive	tract	
infections	 
	 	 	 
Urinary	tract	infections	 	 	 	 
Acute	urinary	retention	 	 	 	 
Dysuria	 	 	 	 
Damage	to	urethra	and	adjacent	
tissues	 
	 	 	 











Cesarean	section	 	 	 	 
Postpartum	hemorrhage		 	 	 	 
Episiotomy	 	 	 	 
Prolonged	labor		 	 	 	 
Obstetrical	tears/lacerations	 	 	 	 
Instrumental	delivery	 	 	 	 
Labor	dystocia	 	 	 	 
Extended	maternal	hospital	stay	 	 	 	 
Stillbirth	or	early	neonatal	death	 	 	 	 











	 	 	 
Reduced	frequency	of	orgasm	or	
anorgasmia	 
	 	 	 
Dyspareunia	(pain	with	sex)	 	 	 	 
Decreased	sexual	satisfaction	 	 	 	 









PTSD	 	 	 	 
Anxiety	 	 	 	 










Chronic	vulvar	and	clitoral	pain	 	 	 	 
Recurrent	genital	tract	infections	 	 	 	 
Dysmenorrhea	 	 	 	 
Recurrent	UTIs	 	 	 	 
















	 	 	 	 
Health	Care	Providers	who	perform	any	form	of	FGC,	including	
symbolic	nicking,	should	be	charged	with	a	crime	 
	 	 	 	 
Adult	women	have	the	right	to	undergo	FGC	 	 	 	 	 
Parents	have	the	right	to	have	their	daughters	circumcised	
(undergo	FGC)	 



















	 	 	 	 
Communities	that	practice	FGC	are	honoring	an	important	
cultural	tradition	 
	 	 	 	 
Parents	who	have	their	daughter	circumcised	are	abusing	
them	 
	 	 	 	 
Parents	who	have	their	daughter	circumcised	are	protecting	
her	future	marriage	prospects   
	 	 	 	 
Women	who	have	undergone	FGC	are	empowered	agents	 	 	 	 	 
Women	who	have	undergone	FGC	are	victims	of	an	oppressive	
cultural	practice	 














	 	 	 	 
On	identification	of	a	woman	with	FGC,	I	can	assign	the	
appropriate	WHO	Type	classification		 




	 	 	 	 
Conduct	an	effective	reproductive/sexual	health	history	via	an	
interpreter	 
	 	 	 	 
Respond	to	the	health	concerns	of	women	with	FGC	by	
engaging	in	non-judgmental	listening	 
	 	 	 	 
Counsel	women	on	the	possible	complications	she	may	
experience	related	to	FGC	 
	 	 	 	 
Discuss	defibulation	with	pregnant	women	who	have	
undergone	Type	3	FGC	in	a	culturally	sensitive	manner	 
	 	 	 	 
Perform	defibulation	of	an	FGC-related	vulvar	scar	 	 	 	 	 
Perform	defibulation	during	the	second	stage	of	labor	 	 	 	 	 
Respond	to	a	request	for	reinfibulation	(re-closing	of	
the	vulvar	scar	following	childbirth)	with	cultural	humility	 
	 	 	 	 
Create	a	positive	therapeutic	relationship	with	a	patient	who	
is	refuses	a	recommended	procedure	 









I. Please tell me about your past experiences learning about FGM. 
a. Probe: Did you receive any training?  
b. Probe: Was your training adequate? 
II. I’d like to learn more about what you think are the most important things that health care 
providers should know when caring for women with FGM? 
a. Probe: What are specific care-related issues related to FGM type? 
b. Probe: Are there particular biomedical or physiological aspects of care that a 
health care provider caring for an FGM-Affected woman or girl should know? 
c. Probe: Are there particular psychological aspects of care that a health care 
provider caring for an FGM-Affected woman or girl should know? 
d. Probe: Are there particular social or community related factors that a health care 
provider caring for an FGM-Affected woman or girl should know? 
III. What do you think health care providers need to know about sexual function for women 
with FGM?  
IV. What are some barriers that women face in getting care for problems associated with 
FGM?  
a. Clarification: Barriers might include structural barriers (cost, health care system), 
or individual (lack of knowledge that care is available, normalization of adverse 
effects, a family member limiting access to care). 
b. Probe: Are there ways you think that health care providers could help minimize 
or lessen some of these barriers? 
V. What are some ethical considerations related to FGM-related care for women and girls 
that health care providers should address? 
VI. Is there anything else you would like to add about health care provider knowledge caring 
for women and girls by FGM? 
 
Practices 
I. What kinds of clinical practices do you think researchers (WHO?) should measure when 
they study health care providers caring for women and girls affected by FGM? 
II. What are some clinical practices by health care providers in the care of women with 
FGM that could improve health outcomes for FGM-affected women and girls? 
III. What are some clinical practices by health care providers in the care of women with 
FGM that may be worsening health outcomes for FGM-affected women and girls?  
IV. For women considering defibulation, what steps should a health care provider take 
before, during and after the procedure? 
V. Are there other surgical procedures health care providers should be aware of in order to 
care for women and girls affected by FGM?  
a. Probe: Can you describe more about what should happen before, during, and after 
this procedure? 
b. Probe: Are you familiar with clitoral reconstruction? (If yes . . .) Can you 
describe more about what should happen before, during, and after this procedure? 
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Now I have some questions about how a health care provider might respond when faced a 
patient request related to FGM:  
VI. What do you do or say when a woman requests reinfibulation? 
VII. What do you do/say when a family asks you to perform FGM on her daughter? (type 
I/II/III/IV) 
VIII. How might a health care provider contribute to the prevention of FGM? 
IX. Is there anything else you would like to add about health care provider practices caring 
for women and girls by FGM? 
 
Attitudes 
I. Tell me about your past experiences taking care of women who have FGM? 
a. For example, tell me about how you relate to them in the clinical setting? 
b. Have you had any positive experiences? Tell me more 
c. Have you had any negative experiences? Tell me more 
II. Tell me about what you think about the practice of FGM? 
a. Probe: Do you think FGM causes any harm? 
b. Probe: Do you think FGM has any benefits? 
III.  How have your past experiences with FGM affected how you think or feel about the 
practices? 
a. Probe: How has your training around FGM affected your feelings toward FGM as 
a practice? 
b. Probe: How has your training around FGM affected your feelings toward the 
women and girls affected by FGM? 
c. Probe: How has your training around FGM affected your feelings toward the 
communities that continue to practice FGM? 
IV. How might a health care provider’s feelings toward FGM affect the patient? 
a. Probe: What about the patient’s relationship with their provider? 
b. Probe: What about a patient’s health seeking behavior? 
c. Probe:  What about the patient’s choice of a treatment? 
V. Why do you think some health care providers perform FGM?  
a. Clarification: When health care providers perform FGM it is often referred to as 
“medicalization.” 
VI. Is there some experience that you have had that most strongly influences your beliefs or 
feelings toward FGM? 
a. Probe: What do you think is the role of a hospital or department of health in 
regulating the practice of FGM?  
b. Probe: What do you think is the role of a hospital or department of health in 
regulating the care of women and girls affected by FGM? 
c. Probe: Can you tell me if some policy at your hospital/ department of health/ 
institution has influenced or changed your attitudes towards FGM? 
Now I have some questions about the role of family and culture for women and girls affected by 
FGM: 
VII. What do you think is the role of the patient’s partner? Family? In-laws in decision 
making about FGM? 
a. Probe: What are some considerations for married vs. unmarried adult women? 
b. Probe: What are some considerations around care of the pediatric patient affected 
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by FGM? What is the role of the parents? 
VIII. What do you think of women who have been cut? And of those who are not cut? 
IX. How might a health care provider’s attitudes toward communities/ religions/ ethnicities/ 
nationalities that practice FGM affect the patient? 
X. What social norms and values might influence a health care provider’s attitudes towards 
the practice of FGM? 
a. Probe: Towards women and girls affected by FGM 
b. Probe: Towards communities that practice FGM 
c. Probe: Towards the clinical care of women with FGM 
XI. Can you tell me about any community or social norms that have particularly influenced 
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